{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "f2e09b73-bc6c-471c-bc3e-dac8a75c1f90",
   "metadata": {},
   "source": [
    "# About Me\n",
    "\n",
    "**Mohammed Imam Uddin Riad**  \n",
    "**Data Analyst**\n",
    "\n",
    "**Connect With Me**\n",
    "- [Portfolio](https://mriadg.github.io/MohammedRiad.com/)\n",
    "- [LinkedIn](https://www.linkedin.com/in/mohammed-imam-uddin-riad-1b7b682ab/)\n",
    "- [Email Me](mailto:imamuddinriad@gmail.com)\n",
    "\r\n",
    "Email Me"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c102d95f-d130-4318-8fb4-d5ec40a400d8",
   "metadata": {},
   "source": [
    "# Project:Exploratory Data Analysis of 250k Medicines Usage, Side Effects and Substitutes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 348,
   "id": "f7add180-3f61-4bfd-aba6-120a04cfcf16",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "059afff7-c01e-4757-b95b-9c3de2ae5485",
   "metadata": {},
   "source": [
    "# Importing Dataset and Checking Basic Info"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 349,
   "id": "fc80de4e-4665-4628-8963-9d7ee6c776e1",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\Mohammed Riad\\AppData\\Local\\Temp\\ipykernel_14468\\1691797094.py:2: DtypeWarning: Columns (42,43,44,45,46,47,48) have mixed types. Specify dtype option on import or set low_memory=False.\n",
      "  raw_data = pd.read_csv(fname)\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>name</th>\n",
       "      <th>substitute0</th>\n",
       "      <th>substitute1</th>\n",
       "      <th>substitute2</th>\n",
       "      <th>substitute3</th>\n",
       "      <th>substitute4</th>\n",
       "      <th>sideEffect0</th>\n",
       "      <th>sideEffect1</th>\n",
       "      <th>sideEffect2</th>\n",
       "      <th>...</th>\n",
       "      <th>sideEffect41</th>\n",
       "      <th>use0</th>\n",
       "      <th>use1</th>\n",
       "      <th>use2</th>\n",
       "      <th>use3</th>\n",
       "      <th>use4</th>\n",
       "      <th>Chemical Class</th>\n",
       "      <th>Habit Forming</th>\n",
       "      <th>Therapeutic Class</th>\n",
       "      <th>Action Class</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>augmentin 625 duo tablet</td>\n",
       "      <td>Penciclav 500 mg/125 mg Tablet</td>\n",
       "      <td>Moxikind-CV 625 Tablet</td>\n",
       "      <td>Moxiforce-CV 625 Tablet</td>\n",
       "      <td>Fightox 625 Tablet</td>\n",
       "      <td>Novamox CV 625mg Tablet</td>\n",
       "      <td>Vomiting</td>\n",
       "      <td>Nausea</td>\n",
       "      <td>Diarrhea</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Treatment of Bacterial infections</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>ANTI INFECTIVES</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>azithral 500 tablet</td>\n",
       "      <td>Zithrocare 500mg Tablet</td>\n",
       "      <td>Azax 500 Tablet</td>\n",
       "      <td>Zady 500 Tablet</td>\n",
       "      <td>Cazithro 500mg Tablet</td>\n",
       "      <td>Trulimax 500mg Tablet</td>\n",
       "      <td>Vomiting</td>\n",
       "      <td>Nausea</td>\n",
       "      <td>Abdominal pain</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Treatment of Bacterial infections</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Macrolides</td>\n",
       "      <td>No</td>\n",
       "      <td>ANTI INFECTIVES</td>\n",
       "      <td>Macrolides</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3</td>\n",
       "      <td>ascoril ls syrup</td>\n",
       "      <td>Solvin LS Syrup</td>\n",
       "      <td>Ambrodil-LX Syrup</td>\n",
       "      <td>Zerotuss XP Syrup</td>\n",
       "      <td>Capex LS Syrup</td>\n",
       "      <td>Broxum LS Syrup</td>\n",
       "      <td>Nausea</td>\n",
       "      <td>Vomiting</td>\n",
       "      <td>Diarrhea</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Treatment of Cough with mucus</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>RESPIRATORY</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>4</td>\n",
       "      <td>allegra 120mg tablet</td>\n",
       "      <td>Lcfex Tablet</td>\n",
       "      <td>Etofex 120mg Tablet</td>\n",
       "      <td>Nexofex 120mg Tablet</td>\n",
       "      <td>Fexise 120mg Tablet</td>\n",
       "      <td>Histafree 120 Tablet</td>\n",
       "      <td>Headache</td>\n",
       "      <td>Drowsiness</td>\n",
       "      <td>Dizziness</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Treatment of Sneezing and runny nose due to al...</td>\n",
       "      <td>Treatment of Allergic conditions</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Diphenylmethane Derivative</td>\n",
       "      <td>No</td>\n",
       "      <td>RESPIRATORY</td>\n",
       "      <td>H1 Antihistaminics (second Generation)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>5</td>\n",
       "      <td>avil 25 tablet</td>\n",
       "      <td>Eralet 25mg Tablet</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Sleepiness</td>\n",
       "      <td>Dryness in mouth</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Treatment of Allergic conditions</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pyridines Derivatives</td>\n",
       "      <td>No</td>\n",
       "      <td>RESPIRATORY</td>\n",
       "      <td>H1 Antihistaminics (First Generation)</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 58 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "   id                      name                     substitute0  \\\n",
       "0   1  augmentin 625 duo tablet  Penciclav 500 mg/125 mg Tablet   \n",
       "1   2       azithral 500 tablet         Zithrocare 500mg Tablet   \n",
       "2   3          ascoril ls syrup                 Solvin LS Syrup   \n",
       "3   4      allegra 120mg tablet                    Lcfex Tablet   \n",
       "4   5            avil 25 tablet              Eralet 25mg Tablet   \n",
       "\n",
       "              substitute1              substitute2            substitute3  \\\n",
       "0  Moxikind-CV 625 Tablet  Moxiforce-CV 625 Tablet     Fightox 625 Tablet   \n",
       "1         Azax 500 Tablet          Zady 500 Tablet  Cazithro 500mg Tablet   \n",
       "2       Ambrodil-LX Syrup        Zerotuss XP Syrup         Capex LS Syrup   \n",
       "3     Etofex 120mg Tablet     Nexofex 120mg Tablet    Fexise 120mg Tablet   \n",
       "4                     NaN                      NaN                    NaN   \n",
       "\n",
       "               substitute4 sideEffect0       sideEffect1     sideEffect2  ...  \\\n",
       "0  Novamox CV 625mg Tablet    Vomiting            Nausea        Diarrhea  ...   \n",
       "1    Trulimax 500mg Tablet    Vomiting            Nausea  Abdominal pain  ...   \n",
       "2          Broxum LS Syrup      Nausea          Vomiting        Diarrhea  ...   \n",
       "3     Histafree 120 Tablet    Headache        Drowsiness       Dizziness  ...   \n",
       "4                      NaN  Sleepiness  Dryness in mouth             NaN  ...   \n",
       "\n",
       "  sideEffect41                                               use0  \\\n",
       "0          NaN                  Treatment of Bacterial infections   \n",
       "1          NaN                  Treatment of Bacterial infections   \n",
       "2          NaN                      Treatment of Cough with mucus   \n",
       "3          NaN  Treatment of Sneezing and runny nose due to al...   \n",
       "4          NaN                   Treatment of Allergic conditions   \n",
       "\n",
       "                               use1 use2 use3 use4  \\\n",
       "0                               NaN  NaN  NaN  NaN   \n",
       "1                               NaN  NaN  NaN  NaN   \n",
       "2                               NaN  NaN  NaN  NaN   \n",
       "3  Treatment of Allergic conditions  NaN  NaN  NaN   \n",
       "4                               NaN  NaN  NaN  NaN   \n",
       "\n",
       "               Chemical Class Habit Forming Therapeutic Class  \\\n",
       "0                         NaN            No   ANTI INFECTIVES   \n",
       "1                  Macrolides            No   ANTI INFECTIVES   \n",
       "2                         NaN            No       RESPIRATORY   \n",
       "3  Diphenylmethane Derivative            No       RESPIRATORY   \n",
       "4       Pyridines Derivatives            No       RESPIRATORY   \n",
       "\n",
       "                             Action Class  \n",
       "0                                     NaN  \n",
       "1                              Macrolides  \n",
       "2                                     NaN  \n",
       "3  H1 Antihistaminics (second Generation)  \n",
       "4   H1 Antihistaminics (First Generation)  \n",
       "\n",
       "[5 rows x 58 columns]"
      ]
     },
     "execution_count": 349,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "fname = \"250k Medicines Usage, Side Effects and Substitutes.csv\"\n",
    "raw_data = pd.read_csv(fname)\n",
    "df= raw_data.copy()\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 350,
   "id": "3adfb410-1cd5-464f-9ad1-55bb100c66a5",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 248218 entries, 0 to 248217\n",
      "Data columns (total 58 columns):\n",
      " #   Column             Non-Null Count   Dtype \n",
      "---  ------             --------------   ----- \n",
      " 0   id                 248218 non-null  int64 \n",
      " 1   name               248218 non-null  object\n",
      " 2   substitute0        238621 non-null  object\n",
      " 3   substitute1        233867 non-null  object\n",
      " 4   substitute2        230233 non-null  object\n",
      " 5   substitute3        226856 non-null  object\n",
      " 6   substitute4        223962 non-null  object\n",
      " 7   sideEffect0        248218 non-null  object\n",
      " 8   sideEffect1        238416 non-null  object\n",
      " 9   sideEffect2        229500 non-null  object\n",
      " 10  sideEffect3        207638 non-null  object\n",
      " 11  sideEffect4        163560 non-null  object\n",
      " 12  sideEffect5        131258 non-null  object\n",
      " 13  sideEffect6        91857 non-null   object\n",
      " 14  sideEffect7        67750 non-null   object\n",
      " 15  sideEffect8        48506 non-null   object\n",
      " 16  sideEffect9        37708 non-null   object\n",
      " 17  sideEffect10       27274 non-null   object\n",
      " 18  sideEffect11       20331 non-null   object\n",
      " 19  sideEffect12       16282 non-null   object\n",
      " 20  sideEffect13       14727 non-null   object\n",
      " 21  sideEffect14       10419 non-null   object\n",
      " 22  sideEffect15       7681 non-null    object\n",
      " 23  sideEffect16       6009 non-null    object\n",
      " 24  sideEffect17       5382 non-null    object\n",
      " 25  sideEffect18       4515 non-null    object\n",
      " 26  sideEffect19       3946 non-null    object\n",
      " 27  sideEffect20       3223 non-null    object\n",
      " 28  sideEffect21       3125 non-null    object\n",
      " 29  sideEffect22       3048 non-null    object\n",
      " 30  sideEffect23       2905 non-null    object\n",
      " 31  sideEffect24       2723 non-null    object\n",
      " 32  sideEffect25       1503 non-null    object\n",
      " 33  sideEffect26       1503 non-null    object\n",
      " 34  sideEffect27       1494 non-null    object\n",
      " 35  sideEffect28       1494 non-null    object\n",
      " 36  sideEffect29       1438 non-null    object\n",
      " 37  sideEffect30       1329 non-null    object\n",
      " 38  sideEffect31       1329 non-null    object\n",
      " 39  sideEffect32       1328 non-null    object\n",
      " 40  sideEffect33       1169 non-null    object\n",
      " 41  sideEffect34       1166 non-null    object\n",
      " 42  sideEffect35       2 non-null       object\n",
      " 43  sideEffect36       2 non-null       object\n",
      " 44  sideEffect37       2 non-null       object\n",
      " 45  sideEffect38       2 non-null       object\n",
      " 46  sideEffect39       2 non-null       object\n",
      " 47  sideEffect40       2 non-null       object\n",
      " 48  sideEffect41       2 non-null       object\n",
      " 49  use0               248218 non-null  object\n",
      " 50  use1               73365 non-null   object\n",
      " 51  use2               28307 non-null   object\n",
      " 52  use3               7379 non-null    object\n",
      " 53  use4               4971 non-null    object\n",
      " 54  Chemical Class     137791 non-null  object\n",
      " 55  Habit Forming      248218 non-null  object\n",
      " 56  Therapeutic Class  248149 non-null  object\n",
      " 57  Action Class       138036 non-null  object\n",
      "dtypes: int64(1), object(57)\n",
      "memory usage: 109.8+ MB\n"
     ]
    }
   ],
   "source": [
    "df.info()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "909dd24f-b1c4-4864-bcdb-5fb2eb2ebe02",
   "metadata": {},
   "source": [
    "###### This Dataset Has Total 58 columns.It has \n",
    "    -5 substitutes columnns\n",
    "    -42 sideeffects columns\n",
    "    -5 uses columns\n",
    "    -and 4 class columns"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0e5df291-312c-4e38-837e-1b7b7bff5ab7",
   "metadata": {},
   "source": [
    "# Data Cleaning And Processing"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "784dd4ce-987e-4565-9c6c-8f768e4d2f10",
   "metadata": {},
   "source": [
    "### Dropping Unneccessary column"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 351,
   "id": "d1c18768-2469-4127-82b4-a2b58d03a812",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>name</th>\n",
       "      <th>substitute0</th>\n",
       "      <th>substitute1</th>\n",
       "      <th>substitute2</th>\n",
       "      <th>substitute3</th>\n",
       "      <th>substitute4</th>\n",
       "      <th>sideEffect0</th>\n",
       "      <th>sideEffect1</th>\n",
       "      <th>sideEffect2</th>\n",
       "      <th>sideEffect3</th>\n",
       "      <th>...</th>\n",
       "      <th>sideEffect41</th>\n",
       "      <th>use0</th>\n",
       "      <th>use1</th>\n",
       "      <th>use2</th>\n",
       "      <th>use3</th>\n",
       "      <th>use4</th>\n",
       "      <th>Chemical Class</th>\n",
       "      <th>Habit Forming</th>\n",
       "      <th>Therapeutic Class</th>\n",
       "      <th>Action Class</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>augmentin 625 duo tablet</td>\n",
       "      <td>Penciclav 500 mg/125 mg Tablet</td>\n",
       "      <td>Moxikind-CV 625 Tablet</td>\n",
       "      <td>Moxiforce-CV 625 Tablet</td>\n",
       "      <td>Fightox 625 Tablet</td>\n",
       "      <td>Novamox CV 625mg Tablet</td>\n",
       "      <td>Vomiting</td>\n",
       "      <td>Nausea</td>\n",
       "      <td>Diarrhea</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Treatment of Bacterial infections</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>ANTI INFECTIVES</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>azithral 500 tablet</td>\n",
       "      <td>Zithrocare 500mg Tablet</td>\n",
       "      <td>Azax 500 Tablet</td>\n",
       "      <td>Zady 500 Tablet</td>\n",
       "      <td>Cazithro 500mg Tablet</td>\n",
       "      <td>Trulimax 500mg Tablet</td>\n",
       "      <td>Vomiting</td>\n",
       "      <td>Nausea</td>\n",
       "      <td>Abdominal pain</td>\n",
       "      <td>Diarrhea</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Treatment of Bacterial infections</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Macrolides</td>\n",
       "      <td>No</td>\n",
       "      <td>ANTI INFECTIVES</td>\n",
       "      <td>Macrolides</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>ascoril ls syrup</td>\n",
       "      <td>Solvin LS Syrup</td>\n",
       "      <td>Ambrodil-LX Syrup</td>\n",
       "      <td>Zerotuss XP Syrup</td>\n",
       "      <td>Capex LS Syrup</td>\n",
       "      <td>Broxum LS Syrup</td>\n",
       "      <td>Nausea</td>\n",
       "      <td>Vomiting</td>\n",
       "      <td>Diarrhea</td>\n",
       "      <td>Upset stomach</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Treatment of Cough with mucus</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>RESPIRATORY</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>allegra 120mg tablet</td>\n",
       "      <td>Lcfex Tablet</td>\n",
       "      <td>Etofex 120mg Tablet</td>\n",
       "      <td>Nexofex 120mg Tablet</td>\n",
       "      <td>Fexise 120mg Tablet</td>\n",
       "      <td>Histafree 120 Tablet</td>\n",
       "      <td>Headache</td>\n",
       "      <td>Drowsiness</td>\n",
       "      <td>Dizziness</td>\n",
       "      <td>Nausea</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Treatment of Sneezing and runny nose due to al...</td>\n",
       "      <td>Treatment of Allergic conditions</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Diphenylmethane Derivative</td>\n",
       "      <td>No</td>\n",
       "      <td>RESPIRATORY</td>\n",
       "      <td>H1 Antihistaminics (second Generation)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>avil 25 tablet</td>\n",
       "      <td>Eralet 25mg Tablet</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Sleepiness</td>\n",
       "      <td>Dryness in mouth</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Treatment of Allergic conditions</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pyridines Derivatives</td>\n",
       "      <td>No</td>\n",
       "      <td>RESPIRATORY</td>\n",
       "      <td>H1 Antihistaminics (First Generation)</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 57 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                       name                     substitute0  \\\n",
       "0  augmentin 625 duo tablet  Penciclav 500 mg/125 mg Tablet   \n",
       "1       azithral 500 tablet         Zithrocare 500mg Tablet   \n",
       "2          ascoril ls syrup                 Solvin LS Syrup   \n",
       "3      allegra 120mg tablet                    Lcfex Tablet   \n",
       "4            avil 25 tablet              Eralet 25mg Tablet   \n",
       "\n",
       "              substitute1              substitute2            substitute3  \\\n",
       "0  Moxikind-CV 625 Tablet  Moxiforce-CV 625 Tablet     Fightox 625 Tablet   \n",
       "1         Azax 500 Tablet          Zady 500 Tablet  Cazithro 500mg Tablet   \n",
       "2       Ambrodil-LX Syrup        Zerotuss XP Syrup         Capex LS Syrup   \n",
       "3     Etofex 120mg Tablet     Nexofex 120mg Tablet    Fexise 120mg Tablet   \n",
       "4                     NaN                      NaN                    NaN   \n",
       "\n",
       "               substitute4 sideEffect0       sideEffect1     sideEffect2  \\\n",
       "0  Novamox CV 625mg Tablet    Vomiting            Nausea        Diarrhea   \n",
       "1    Trulimax 500mg Tablet    Vomiting            Nausea  Abdominal pain   \n",
       "2          Broxum LS Syrup      Nausea          Vomiting        Diarrhea   \n",
       "3     Histafree 120 Tablet    Headache        Drowsiness       Dizziness   \n",
       "4                      NaN  Sleepiness  Dryness in mouth             NaN   \n",
       "\n",
       "     sideEffect3  ... sideEffect41  \\\n",
       "0            NaN  ...          NaN   \n",
       "1       Diarrhea  ...          NaN   \n",
       "2  Upset stomach  ...          NaN   \n",
       "3         Nausea  ...          NaN   \n",
       "4            NaN  ...          NaN   \n",
       "\n",
       "                                                use0  \\\n",
       "0                  Treatment of Bacterial infections   \n",
       "1                  Treatment of Bacterial infections   \n",
       "2                      Treatment of Cough with mucus   \n",
       "3  Treatment of Sneezing and runny nose due to al...   \n",
       "4                   Treatment of Allergic conditions   \n",
       "\n",
       "                               use1 use2 use3 use4  \\\n",
       "0                               NaN  NaN  NaN  NaN   \n",
       "1                               NaN  NaN  NaN  NaN   \n",
       "2                               NaN  NaN  NaN  NaN   \n",
       "3  Treatment of Allergic conditions  NaN  NaN  NaN   \n",
       "4                               NaN  NaN  NaN  NaN   \n",
       "\n",
       "               Chemical Class Habit Forming Therapeutic Class  \\\n",
       "0                         NaN            No   ANTI INFECTIVES   \n",
       "1                  Macrolides            No   ANTI INFECTIVES   \n",
       "2                         NaN            No       RESPIRATORY   \n",
       "3  Diphenylmethane Derivative            No       RESPIRATORY   \n",
       "4       Pyridines Derivatives            No       RESPIRATORY   \n",
       "\n",
       "                             Action Class  \n",
       "0                                     NaN  \n",
       "1                              Macrolides  \n",
       "2                                     NaN  \n",
       "3  H1 Antihistaminics (second Generation)  \n",
       "4   H1 Antihistaminics (First Generation)  \n",
       "\n",
       "[5 rows x 57 columns]"
      ]
     },
     "execution_count": 351,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = df.drop(\"id\",axis =1)\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "62e71fc0-58cd-4643-9696-6f40f24618f8",
   "metadata": {},
   "source": [
    "### Dropping Duplicated Rows across all the columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 352,
   "id": "f2deef3c-1572-4454-8216-026022d632f9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 352,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.duplicated().any()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 353,
   "id": "2513133b-c4b6-4f4a-b831-a64e436a8faf",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "False"
      ]
     },
     "execution_count": 353,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Drop duplicated rows, keeping only the first occurrence\n",
    "df = df.drop_duplicates()\n",
    "#checking again is there any duplicated rows after deletetion\n",
    "df.duplicated().any()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f7f37660-2162-4326-abed-713a90ee9006",
   "metadata": {},
   "source": [
    "### Working With Missing Values"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 354,
   "id": "c9fa2a8e-ef89-4973-a187-a39d48eea963",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "name               0\n",
       "substitute0     8820\n",
       "substitute1    13196\n",
       "substitute2    16574\n",
       "substitute3    19692\n",
       "dtype: int64"
      ]
     },
     "execution_count": 354,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.isnull().sum().head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 355,
   "id": "8cdd90e9-4c47-4fef-b5aa-4497c06d2511",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Column</th>\n",
       "      <th>null_count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>substitute0</td>\n",
       "      <td>8820</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>substitute1</td>\n",
       "      <td>13196</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>substitute2</td>\n",
       "      <td>16574</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>substitute3</td>\n",
       "      <td>19692</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>substitute4</td>\n",
       "      <td>22357</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        Column  null_count\n",
       "0  substitute0        8820\n",
       "1  substitute1       13196\n",
       "2  substitute2       16574\n",
       "3  substitute3       19692\n",
       "4  substitute4       22357"
      ]
     },
     "execution_count": 355,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#making a dataframe with the missing values of the dataset\n",
    "\n",
    "null_counts = df.isnull().sum()\n",
    "missing_value =  pd.DataFrame(null_counts, columns=['null_count']).reset_index()\n",
    "missing_value = missing_value.rename(columns={'index': 'Column'})\n",
    "\n",
    "# Drop the first two row namem,as name has no missing value\n",
    "missing_value = missing_value.drop([0]).reset_index(drop=True)\n",
    "\n",
    "\n",
    "missing_value.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 356,
   "id": "1cf34295-1b30-4408-aec6-c7c5dc0d0ed4",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1400x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "#creating a barplot with the missing value\n",
    "\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "\n",
    "plt.figure(figsize=(14, 6))\n",
    "sns.barplot(x='Column', y='null_count', data=missing_value, color ='red')\n",
    "\n",
    "plt.xlabel('columns')\n",
    "plt.ylabel('missing_value')\n",
    "plt.title(\"missing value graph\")\n",
    "plt.xticks(rotation=90)  # Rotate x-axis labels if necessary\n",
    "plt.show()\n",
    "\n",
    "# Show the plot\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 357,
   "id": "1c1e6827-2934-48cf-8bf0-20657f0024bf",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "name                 0\n",
       "substitute0          0\n",
       "substitute1          0\n",
       "substitute2          0\n",
       "substitute3          0\n",
       "substitute4          0\n",
       "sideEffect0          0\n",
       "sideEffect1          0\n",
       "sideEffect2          0\n",
       "sideEffect3          0\n",
       "sideEffect4          0\n",
       "sideEffect5          0\n",
       "sideEffect6          0\n",
       "sideEffect7          0\n",
       "sideEffect8          0\n",
       "sideEffect9          0\n",
       "sideEffect10         0\n",
       "sideEffect11         0\n",
       "sideEffect12         0\n",
       "sideEffect13         0\n",
       "sideEffect14         0\n",
       "sideEffect15         0\n",
       "sideEffect16         0\n",
       "sideEffect17         0\n",
       "sideEffect18         0\n",
       "sideEffect19         0\n",
       "sideEffect20         0\n",
       "sideEffect21         0\n",
       "sideEffect22         0\n",
       "sideEffect23         0\n",
       "sideEffect24         0\n",
       "sideEffect25         0\n",
       "sideEffect26         0\n",
       "sideEffect27         0\n",
       "sideEffect28         0\n",
       "sideEffect29         0\n",
       "sideEffect30         0\n",
       "sideEffect31         0\n",
       "sideEffect32         0\n",
       "sideEffect33         0\n",
       "sideEffect34         0\n",
       "sideEffect35         0\n",
       "sideEffect36         0\n",
       "sideEffect37         0\n",
       "sideEffect38         0\n",
       "sideEffect39         0\n",
       "sideEffect40         0\n",
       "sideEffect41         0\n",
       "use0                 0\n",
       "use1                 0\n",
       "use2                 0\n",
       "use3                 0\n",
       "use4                 0\n",
       "Chemical Class       0\n",
       "Habit Forming        0\n",
       "Therapeutic Class    0\n",
       "Action Class         0\n",
       "dtype: int64"
      ]
     },
     "execution_count": 357,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#filling the missing values with unknown\n",
    "df.fillna(\"UnKnown\",inplace = True)\n",
    "\n",
    "#checking is there any missing value remaining\n",
    "df.isnull().sum()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "92481226-8653-4a5e-a579-56ab9364e112",
   "metadata": {},
   "source": [
    "## Creating Checkpoint 1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 358,
   "id": "5db5410a-938a-40ab-b912-79a1ada662db",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_cleaned = df.copy()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "85d9518b-9978-4b9e-9f7a-59e6f547197b",
   "metadata": {},
   "source": [
    "# EDA(Exploratory Data Analysis.)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f03d08e0-9ef4-4685-a608-69f933247f31",
   "metadata": {},
   "source": [
    "### Explore how many sideeffects each medicine has and identify medicines with the most substitutes."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 359,
   "id": "c92ea032-28a9-4a60-90b8-a31e876c36da",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>sideEffect0</th>\n",
       "      <th>sideEffect1</th>\n",
       "      <th>sideEffect2</th>\n",
       "      <th>sideEffect3</th>\n",
       "      <th>sideEffect4</th>\n",
       "      <th>sideEffect5</th>\n",
       "      <th>sideEffect6</th>\n",
       "      <th>sideEffect7</th>\n",
       "      <th>sideEffect8</th>\n",
       "      <th>sideEffect9</th>\n",
       "      <th>...</th>\n",
       "      <th>sideEffect32</th>\n",
       "      <th>sideEffect33</th>\n",
       "      <th>sideEffect34</th>\n",
       "      <th>sideEffect35</th>\n",
       "      <th>sideEffect36</th>\n",
       "      <th>sideEffect37</th>\n",
       "      <th>sideEffect38</th>\n",
       "      <th>sideEffect39</th>\n",
       "      <th>sideEffect40</th>\n",
       "      <th>sideEffect41</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Vomiting</td>\n",
       "      <td>Nausea</td>\n",
       "      <td>Diarrhea</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>...</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Vomiting</td>\n",
       "      <td>Nausea</td>\n",
       "      <td>Abdominal pain</td>\n",
       "      <td>Diarrhea</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>...</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Nausea</td>\n",
       "      <td>Vomiting</td>\n",
       "      <td>Diarrhea</td>\n",
       "      <td>Upset stomach</td>\n",
       "      <td>Stomach pain</td>\n",
       "      <td>Allergic reaction</td>\n",
       "      <td>Dizziness</td>\n",
       "      <td>Headache</td>\n",
       "      <td>Rash</td>\n",
       "      <td>Hives</td>\n",
       "      <td>...</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>3 rows × 42 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "  sideEffect0 sideEffect1     sideEffect2    sideEffect3   sideEffect4  \\\n",
       "0    Vomiting      Nausea        Diarrhea        UnKnown       UnKnown   \n",
       "1    Vomiting      Nausea  Abdominal pain       Diarrhea       UnKnown   \n",
       "2      Nausea    Vomiting        Diarrhea  Upset stomach  Stomach pain   \n",
       "\n",
       "         sideEffect5 sideEffect6 sideEffect7 sideEffect8 sideEffect9  ...  \\\n",
       "0            UnKnown     UnKnown     UnKnown     UnKnown     UnKnown  ...   \n",
       "1            UnKnown     UnKnown     UnKnown     UnKnown     UnKnown  ...   \n",
       "2  Allergic reaction   Dizziness    Headache        Rash       Hives  ...   \n",
       "\n",
       "  sideEffect32 sideEffect33 sideEffect34 sideEffect35 sideEffect36  \\\n",
       "0      UnKnown      UnKnown      UnKnown      UnKnown      UnKnown   \n",
       "1      UnKnown      UnKnown      UnKnown      UnKnown      UnKnown   \n",
       "2      UnKnown      UnKnown      UnKnown      UnKnown      UnKnown   \n",
       "\n",
       "  sideEffect37 sideEffect38 sideEffect39 sideEffect40 sideEffect41  \n",
       "0      UnKnown      UnKnown      UnKnown      UnKnown      UnKnown  \n",
       "1      UnKnown      UnKnown      UnKnown      UnKnown      UnKnown  \n",
       "2      UnKnown      UnKnown      UnKnown      UnKnown      UnKnown  \n",
       "\n",
       "[3 rows x 42 columns]"
      ]
     },
     "execution_count": 359,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Create a list of side effect columns\n",
    "side_effect_columns = [col for col in df_cleaned.columns if 'sideEffect' in col]\n",
    "\n",
    "df_cleaned[side_effect_columns].head(3)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 360,
   "id": "38e18ca3-3889-4fe8-a455-e8a75ea04f19",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>name</th>\n",
       "      <th>substitute0</th>\n",
       "      <th>substitute1</th>\n",
       "      <th>substitute2</th>\n",
       "      <th>substitute3</th>\n",
       "      <th>substitute4</th>\n",
       "      <th>sideEffect0</th>\n",
       "      <th>sideEffect1</th>\n",
       "      <th>sideEffect2</th>\n",
       "      <th>sideEffect3</th>\n",
       "      <th>...</th>\n",
       "      <th>use0</th>\n",
       "      <th>use1</th>\n",
       "      <th>use2</th>\n",
       "      <th>use3</th>\n",
       "      <th>use4</th>\n",
       "      <th>Chemical Class</th>\n",
       "      <th>Habit Forming</th>\n",
       "      <th>Therapeutic Class</th>\n",
       "      <th>Action Class</th>\n",
       "      <th>total_side_effect_recorded</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>augmentin 625 duo tablet</td>\n",
       "      <td>Penciclav 500 mg/125 mg Tablet</td>\n",
       "      <td>Moxikind-CV 625 Tablet</td>\n",
       "      <td>Moxiforce-CV 625 Tablet</td>\n",
       "      <td>Fightox 625 Tablet</td>\n",
       "      <td>Novamox CV 625mg Tablet</td>\n",
       "      <td>Vomiting</td>\n",
       "      <td>Nausea</td>\n",
       "      <td>Diarrhea</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>...</td>\n",
       "      <td>Treatment of Bacterial infections</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>No</td>\n",
       "      <td>ANTI INFECTIVES</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>azithral 500 tablet</td>\n",
       "      <td>Zithrocare 500mg Tablet</td>\n",
       "      <td>Azax 500 Tablet</td>\n",
       "      <td>Zady 500 Tablet</td>\n",
       "      <td>Cazithro 500mg Tablet</td>\n",
       "      <td>Trulimax 500mg Tablet</td>\n",
       "      <td>Vomiting</td>\n",
       "      <td>Nausea</td>\n",
       "      <td>Abdominal pain</td>\n",
       "      <td>Diarrhea</td>\n",
       "      <td>...</td>\n",
       "      <td>Treatment of Bacterial infections</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>Macrolides</td>\n",
       "      <td>No</td>\n",
       "      <td>ANTI INFECTIVES</td>\n",
       "      <td>Macrolides</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>ascoril ls syrup</td>\n",
       "      <td>Solvin LS Syrup</td>\n",
       "      <td>Ambrodil-LX Syrup</td>\n",
       "      <td>Zerotuss XP Syrup</td>\n",
       "      <td>Capex LS Syrup</td>\n",
       "      <td>Broxum LS Syrup</td>\n",
       "      <td>Nausea</td>\n",
       "      <td>Vomiting</td>\n",
       "      <td>Diarrhea</td>\n",
       "      <td>Upset stomach</td>\n",
       "      <td>...</td>\n",
       "      <td>Treatment of Cough with mucus</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>No</td>\n",
       "      <td>RESPIRATORY</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>14</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>3 rows × 58 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                       name                     substitute0  \\\n",
       "0  augmentin 625 duo tablet  Penciclav 500 mg/125 mg Tablet   \n",
       "1       azithral 500 tablet         Zithrocare 500mg Tablet   \n",
       "2          ascoril ls syrup                 Solvin LS Syrup   \n",
       "\n",
       "              substitute1              substitute2            substitute3  \\\n",
       "0  Moxikind-CV 625 Tablet  Moxiforce-CV 625 Tablet     Fightox 625 Tablet   \n",
       "1         Azax 500 Tablet          Zady 500 Tablet  Cazithro 500mg Tablet   \n",
       "2       Ambrodil-LX Syrup        Zerotuss XP Syrup         Capex LS Syrup   \n",
       "\n",
       "               substitute4 sideEffect0 sideEffect1     sideEffect2  \\\n",
       "0  Novamox CV 625mg Tablet    Vomiting      Nausea        Diarrhea   \n",
       "1    Trulimax 500mg Tablet    Vomiting      Nausea  Abdominal pain   \n",
       "2          Broxum LS Syrup      Nausea    Vomiting        Diarrhea   \n",
       "\n",
       "     sideEffect3  ...                               use0     use1     use2  \\\n",
       "0        UnKnown  ...  Treatment of Bacterial infections  UnKnown  UnKnown   \n",
       "1       Diarrhea  ...  Treatment of Bacterial infections  UnKnown  UnKnown   \n",
       "2  Upset stomach  ...      Treatment of Cough with mucus  UnKnown  UnKnown   \n",
       "\n",
       "      use3     use4 Chemical Class Habit Forming Therapeutic Class  \\\n",
       "0  UnKnown  UnKnown        UnKnown            No   ANTI INFECTIVES   \n",
       "1  UnKnown  UnKnown     Macrolides            No   ANTI INFECTIVES   \n",
       "2  UnKnown  UnKnown        UnKnown            No       RESPIRATORY   \n",
       "\n",
       "  Action Class total_side_effect_recorded  \n",
       "0      UnKnown                          3  \n",
       "1   Macrolides                          4  \n",
       "2      UnKnown                         14  \n",
       "\n",
       "[3 rows x 58 columns]"
      ]
     },
     "execution_count": 360,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Calculate the count of known side effects for each drug by counting entries that are not \"Unknown\"\n",
    "df_cleaned['total_side_effect_recorded'] = df_cleaned[side_effect_columns].apply(lambda x: (x != \"UnKnown\").sum(), axis=1)\n",
    "df_cleaned.head(3)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 361,
   "id": "789aa934-5d7d-494d-ac7c-fd8c6ab1d43b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>name</th>\n",
       "      <th>total_side_effect_recorded</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>30664</th>\n",
       "      <td>balila capsule</td>\n",
       "      <td>42</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30832</th>\n",
       "      <td>balila 25mg capsule</td>\n",
       "      <td>42</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>235196</th>\n",
       "      <td>waycef o 200mg/200mg tablet</td>\n",
       "      <td>35</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>235198</th>\n",
       "      <td>wincef-o tablet</td>\n",
       "      <td>35</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37699</th>\n",
       "      <td>brefix o 200mg/200mg tablet</td>\n",
       "      <td>35</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46980</th>\n",
       "      <td>ceftrue-o tablet</td>\n",
       "      <td>35</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>235822</th>\n",
       "      <td>winfex o 200mg/200mg tablet</td>\n",
       "      <td>35</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>142110</th>\n",
       "      <td>milixim-o tablet</td>\n",
       "      <td>35</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>169329</th>\n",
       "      <td>netfix-ox tablet</td>\n",
       "      <td>35</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48126</th>\n",
       "      <td>cefistar-o tablet</td>\n",
       "      <td>35</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                               name  total_side_effect_recorded\n",
       "30664                balila capsule                          42\n",
       "30832           balila 25mg capsule                          42\n",
       "235196  waycef o 200mg/200mg tablet                          35\n",
       "235198              wincef-o tablet                          35\n",
       "37699   brefix o 200mg/200mg tablet                          35\n",
       "46980              ceftrue-o tablet                          35\n",
       "235822  winfex o 200mg/200mg tablet                          35\n",
       "142110             milixim-o tablet                          35\n",
       "169329             netfix-ox tablet                          35\n",
       "48126             cefistar-o tablet                          35"
      ]
     },
     "execution_count": 361,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Top 10 Medicine that has most Side effects\n",
    "df_cleaned[['name','total_side_effect_recorded']].sort_values(by = 'total_side_effect_recorded',ascending=False).head(10)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e9ac7e58-0dda-47b7-a827-43973ba2d530",
   "metadata": {},
   "source": [
    "### Explore how many substitutes each medicine has "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 362,
   "id": "aef51dd4-202e-461d-bcd3-1f07f40624ef",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>substitute0</th>\n",
       "      <th>substitute1</th>\n",
       "      <th>substitute2</th>\n",
       "      <th>substitute3</th>\n",
       "      <th>substitute4</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Penciclav 500 mg/125 mg Tablet</td>\n",
       "      <td>Moxikind-CV 625 Tablet</td>\n",
       "      <td>Moxiforce-CV 625 Tablet</td>\n",
       "      <td>Fightox 625 Tablet</td>\n",
       "      <td>Novamox CV 625mg Tablet</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Zithrocare 500mg Tablet</td>\n",
       "      <td>Azax 500 Tablet</td>\n",
       "      <td>Zady 500 Tablet</td>\n",
       "      <td>Cazithro 500mg Tablet</td>\n",
       "      <td>Trulimax 500mg Tablet</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Solvin LS Syrup</td>\n",
       "      <td>Ambrodil-LX Syrup</td>\n",
       "      <td>Zerotuss XP Syrup</td>\n",
       "      <td>Capex LS Syrup</td>\n",
       "      <td>Broxum LS Syrup</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                      substitute0             substitute1  \\\n",
       "0  Penciclav 500 mg/125 mg Tablet  Moxikind-CV 625 Tablet   \n",
       "1         Zithrocare 500mg Tablet         Azax 500 Tablet   \n",
       "2                 Solvin LS Syrup       Ambrodil-LX Syrup   \n",
       "\n",
       "               substitute2            substitute3              substitute4  \n",
       "0  Moxiforce-CV 625 Tablet     Fightox 625 Tablet  Novamox CV 625mg Tablet  \n",
       "1          Zady 500 Tablet  Cazithro 500mg Tablet    Trulimax 500mg Tablet  \n",
       "2        Zerotuss XP Syrup         Capex LS Syrup          Broxum LS Syrup  "
      ]
     },
     "execution_count": 362,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Create a list of substitute columns\n",
    "substitute_columns = [col for col in df_cleaned.columns if 'substitute' in col]\n",
    "\n",
    "df_cleaned[substitute_columns].head(3)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 363,
   "id": "f447c094-60d7-4a43-a62a-0cb10f1c9fb4",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>name</th>\n",
       "      <th>substitute0</th>\n",
       "      <th>substitute1</th>\n",
       "      <th>substitute2</th>\n",
       "      <th>substitute3</th>\n",
       "      <th>substitute4</th>\n",
       "      <th>sideEffect0</th>\n",
       "      <th>sideEffect1</th>\n",
       "      <th>sideEffect2</th>\n",
       "      <th>sideEffect3</th>\n",
       "      <th>...</th>\n",
       "      <th>use1</th>\n",
       "      <th>use2</th>\n",
       "      <th>use3</th>\n",
       "      <th>use4</th>\n",
       "      <th>Chemical Class</th>\n",
       "      <th>Habit Forming</th>\n",
       "      <th>Therapeutic Class</th>\n",
       "      <th>Action Class</th>\n",
       "      <th>total_side_effect_recorded</th>\n",
       "      <th>total_substitute_counts</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>augmentin 625 duo tablet</td>\n",
       "      <td>Penciclav 500 mg/125 mg Tablet</td>\n",
       "      <td>Moxikind-CV 625 Tablet</td>\n",
       "      <td>Moxiforce-CV 625 Tablet</td>\n",
       "      <td>Fightox 625 Tablet</td>\n",
       "      <td>Novamox CV 625mg Tablet</td>\n",
       "      <td>Vomiting</td>\n",
       "      <td>Nausea</td>\n",
       "      <td>Diarrhea</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>...</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>No</td>\n",
       "      <td>ANTI INFECTIVES</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>3</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>azithral 500 tablet</td>\n",
       "      <td>Zithrocare 500mg Tablet</td>\n",
       "      <td>Azax 500 Tablet</td>\n",
       "      <td>Zady 500 Tablet</td>\n",
       "      <td>Cazithro 500mg Tablet</td>\n",
       "      <td>Trulimax 500mg Tablet</td>\n",
       "      <td>Vomiting</td>\n",
       "      <td>Nausea</td>\n",
       "      <td>Abdominal pain</td>\n",
       "      <td>Diarrhea</td>\n",
       "      <td>...</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>Macrolides</td>\n",
       "      <td>No</td>\n",
       "      <td>ANTI INFECTIVES</td>\n",
       "      <td>Macrolides</td>\n",
       "      <td>4</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>ascoril ls syrup</td>\n",
       "      <td>Solvin LS Syrup</td>\n",
       "      <td>Ambrodil-LX Syrup</td>\n",
       "      <td>Zerotuss XP Syrup</td>\n",
       "      <td>Capex LS Syrup</td>\n",
       "      <td>Broxum LS Syrup</td>\n",
       "      <td>Nausea</td>\n",
       "      <td>Vomiting</td>\n",
       "      <td>Diarrhea</td>\n",
       "      <td>Upset stomach</td>\n",
       "      <td>...</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>No</td>\n",
       "      <td>RESPIRATORY</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>14</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>3 rows × 59 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                       name                     substitute0  \\\n",
       "0  augmentin 625 duo tablet  Penciclav 500 mg/125 mg Tablet   \n",
       "1       azithral 500 tablet         Zithrocare 500mg Tablet   \n",
       "2          ascoril ls syrup                 Solvin LS Syrup   \n",
       "\n",
       "              substitute1              substitute2            substitute3  \\\n",
       "0  Moxikind-CV 625 Tablet  Moxiforce-CV 625 Tablet     Fightox 625 Tablet   \n",
       "1         Azax 500 Tablet          Zady 500 Tablet  Cazithro 500mg Tablet   \n",
       "2       Ambrodil-LX Syrup        Zerotuss XP Syrup         Capex LS Syrup   \n",
       "\n",
       "               substitute4 sideEffect0 sideEffect1     sideEffect2  \\\n",
       "0  Novamox CV 625mg Tablet    Vomiting      Nausea        Diarrhea   \n",
       "1    Trulimax 500mg Tablet    Vomiting      Nausea  Abdominal pain   \n",
       "2          Broxum LS Syrup      Nausea    Vomiting        Diarrhea   \n",
       "\n",
       "     sideEffect3  ...     use1     use2     use3     use4 Chemical Class  \\\n",
       "0        UnKnown  ...  UnKnown  UnKnown  UnKnown  UnKnown        UnKnown   \n",
       "1       Diarrhea  ...  UnKnown  UnKnown  UnKnown  UnKnown     Macrolides   \n",
       "2  Upset stomach  ...  UnKnown  UnKnown  UnKnown  UnKnown        UnKnown   \n",
       "\n",
       "  Habit Forming Therapeutic Class Action Class total_side_effect_recorded  \\\n",
       "0            No   ANTI INFECTIVES      UnKnown                          3   \n",
       "1            No   ANTI INFECTIVES   Macrolides                          4   \n",
       "2            No       RESPIRATORY      UnKnown                         14   \n",
       "\n",
       "  total_substitute_counts  \n",
       "0                       5  \n",
       "1                       5  \n",
       "2                       5  \n",
       "\n",
       "[3 rows x 59 columns]"
      ]
     },
     "execution_count": 363,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_cleaned[\"total_substitute_counts\"]=df_cleaned[substitute_columns].apply(lambda x: (x!= 'UnKnown').sum(),axis= 1)\n",
    "df_cleaned.head(3)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ccd6380b-53d3-444a-b948-32fcd5b0752e",
   "metadata": {},
   "source": [
    "### Identify which substitute is used in the highest number of medicines."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 364,
   "id": "4c2b5fb3-fae7-4e11-b08b-f248560e701c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>substitutes</th>\n",
       "      <th>Counts</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>substitute0</td>\n",
       "      <td>215194</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>substitute1</td>\n",
       "      <td>210818</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>substitute2</td>\n",
       "      <td>207440</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>substitute3</td>\n",
       "      <td>204322</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>substitute4</td>\n",
       "      <td>201657</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   substitutes  Counts\n",
       "0  substitute0  215194\n",
       "1  substitute1  210818\n",
       "2  substitute2  207440\n",
       "3  substitute3  204322\n",
       "4  substitute4  201657"
      ]
     },
     "execution_count": 364,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Count non-\"Unknown\" values for each substitute column\n",
    "substitute_counts = pd.DataFrame(df_cleaned[substitute_columns].apply(lambda col: (col != \"UnKnown\")).sum(axis = 0),columns= ['Counts']).reset_index()\n",
    "substitute_counts=substitute_counts.rename(columns={'index':'substitutes'})\n",
    "substitute_counts"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 365,
   "id": "63096f96-d45b-4a67-8ffa-f3f4f36063ca",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x400 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "#creating a line with the missing value\n",
    "\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "\n",
    "plt.figure(figsize=(10, 4))\n",
    "sns.lineplot(x='substitutes', y='Counts', data=substitute_counts, color ='red')\n",
    "\n",
    "plt.xlabel('Substitutes')\n",
    "plt.ylabel('Substitutes Count')\n",
    "plt.title(\"Substitutes VS Substitutes Counted\")\n",
    "plt.xticks(rotation=0)  \n",
    "plt.show()\n",
    "\n",
    "# Show the plot\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e8e4f7f8-c420-4488-b9ef-54600e219195",
   "metadata": {},
   "source": [
    "### Explore the total uses of the medicines"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 366,
   "id": "ff432474-3156-48d5-9df5-722a62d68c56",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['use0', 'use1', 'use2', 'use3', 'use4']"
      ]
     },
     "execution_count": 366,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "use_columns = [f'use{i}' for i in range(5)]\n",
    "use_columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 367,
   "id": "a0f4a79f-8aeb-4ae3-8ae1-9736d705bf6a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>name</th>\n",
       "      <th>substitute0</th>\n",
       "      <th>substitute1</th>\n",
       "      <th>substitute2</th>\n",
       "      <th>substitute3</th>\n",
       "      <th>substitute4</th>\n",
       "      <th>sideEffect0</th>\n",
       "      <th>sideEffect1</th>\n",
       "      <th>sideEffect2</th>\n",
       "      <th>sideEffect3</th>\n",
       "      <th>...</th>\n",
       "      <th>use2</th>\n",
       "      <th>use3</th>\n",
       "      <th>use4</th>\n",
       "      <th>Chemical Class</th>\n",
       "      <th>Habit Forming</th>\n",
       "      <th>Therapeutic Class</th>\n",
       "      <th>Action Class</th>\n",
       "      <th>total_side_effect_recorded</th>\n",
       "      <th>total_substitute_counts</th>\n",
       "      <th>total_uses</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>152854</th>\n",
       "      <td>mincetam 800mg tablet</td>\n",
       "      <td>Cgtam 800mg Tablet</td>\n",
       "      <td>Leepan 800 Tablet</td>\n",
       "      <td>Geocetam 800mg Tablet</td>\n",
       "      <td>Piramax 800 Tablet</td>\n",
       "      <td>Sumocetam 800 Tablet</td>\n",
       "      <td>Weight gain</td>\n",
       "      <td>Nervousness</td>\n",
       "      <td>Abnormality of voluntary movements</td>\n",
       "      <td>UnKnown</td>\n",
       "      <td>...</td>\n",
       "      <td>Dementia in Parkinson's disease</td>\n",
       "      <td>Age related memory loss</td>\n",
       "      <td>Head injury</td>\n",
       "      <td>Alpha Amino Acids Derivatives</td>\n",
       "      <td>No</td>\n",
       "      <td>NEURO CNS</td>\n",
       "      <td>Nootropic agent</td>\n",
       "      <td>3</td>\n",
       "      <td>5</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>172310</th>\n",
       "      <td>navmit 4mg tablet</td>\n",
       "      <td>Predace 4 Tablet</td>\n",
       "      <td>Coelone 4mg Tablet</td>\n",
       "      <td>Melpred 4mg Tablet</td>\n",
       "      <td>Pilsone 4mg Tablet</td>\n",
       "      <td>Cortilog 4mg Tablet</td>\n",
       "      <td>Thinning of skin</td>\n",
       "      <td>Increased risk of infection</td>\n",
       "      <td>Reduction in bone density</td>\n",
       "      <td>Weight gain</td>\n",
       "      <td>...</td>\n",
       "      <td>Treatment of Allergic conditions</td>\n",
       "      <td>Treatment of Eye disorders</td>\n",
       "      <td>Treatment of Skin disorders</td>\n",
       "      <td>Glucocorticoids</td>\n",
       "      <td>No</td>\n",
       "      <td>HORMONES</td>\n",
       "      <td>Glucocorticoids</td>\n",
       "      <td>7</td>\n",
       "      <td>5</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>235271</th>\n",
       "      <td>walbeta la 20mg tablet</td>\n",
       "      <td>Prograin 20mg Tablet</td>\n",
       "      <td>Nigrain 20mg Tablet</td>\n",
       "      <td>Betagem 20mg Tablet</td>\n",
       "      <td>Signolol 20mg Tablet</td>\n",
       "      <td>Arminol 20mg Tablet</td>\n",
       "      <td>Tiredness</td>\n",
       "      <td>Weakness</td>\n",
       "      <td>Raynaud's phenomenon</td>\n",
       "      <td>Arrhythmia (irregular heartbeats)</td>\n",
       "      <td>...</td>\n",
       "      <td>Prevention of migraine</td>\n",
       "      <td>Treatment of Anxiety</td>\n",
       "      <td>Treatment of Arrhythmia</td>\n",
       "      <td>Naphthalenes derivatives</td>\n",
       "      <td>No</td>\n",
       "      <td>CARDIAC</td>\n",
       "      <td>Beta blocker- Non selective</td>\n",
       "      <td>7</td>\n",
       "      <td>5</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>3 rows × 60 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                          name           substitute0          substitute1  \\\n",
       "152854   mincetam 800mg tablet    Cgtam 800mg Tablet    Leepan 800 Tablet   \n",
       "172310       navmit 4mg tablet      Predace 4 Tablet   Coelone 4mg Tablet   \n",
       "235271  walbeta la 20mg tablet  Prograin 20mg Tablet  Nigrain 20mg Tablet   \n",
       "\n",
       "                  substitute2           substitute3           substitute4  \\\n",
       "152854  Geocetam 800mg Tablet    Piramax 800 Tablet  Sumocetam 800 Tablet   \n",
       "172310     Melpred 4mg Tablet    Pilsone 4mg Tablet   Cortilog 4mg Tablet   \n",
       "235271    Betagem 20mg Tablet  Signolol 20mg Tablet   Arminol 20mg Tablet   \n",
       "\n",
       "             sideEffect0                  sideEffect1  \\\n",
       "152854       Weight gain                  Nervousness   \n",
       "172310  Thinning of skin  Increased risk of infection   \n",
       "235271         Tiredness                     Weakness   \n",
       "\n",
       "                               sideEffect2                        sideEffect3  \\\n",
       "152854  Abnormality of voluntary movements                            UnKnown   \n",
       "172310           Reduction in bone density                        Weight gain   \n",
       "235271                Raynaud's phenomenon  Arrhythmia (irregular heartbeats)   \n",
       "\n",
       "        ...                              use2                        use3  \\\n",
       "152854  ...   Dementia in Parkinson's disease     Age related memory loss   \n",
       "172310  ...  Treatment of Allergic conditions  Treatment of Eye disorders   \n",
       "235271  ...            Prevention of migraine        Treatment of Anxiety   \n",
       "\n",
       "                               use4                 Chemical Class  \\\n",
       "152854                  Head injury  Alpha Amino Acids Derivatives   \n",
       "172310  Treatment of Skin disorders                Glucocorticoids   \n",
       "235271      Treatment of Arrhythmia       Naphthalenes derivatives   \n",
       "\n",
       "       Habit Forming Therapeutic Class                 Action Class  \\\n",
       "152854            No         NEURO CNS              Nootropic agent   \n",
       "172310            No          HORMONES              Glucocorticoids   \n",
       "235271            No           CARDIAC  Beta blocker- Non selective   \n",
       "\n",
       "       total_side_effect_recorded total_substitute_counts total_uses  \n",
       "152854                          3                       5          5  \n",
       "172310                          7                       5          5  \n",
       "235271                          7                       5          5  \n",
       "\n",
       "[3 rows x 60 columns]"
      ]
     },
     "execution_count": 367,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_cleaned['total_uses'] = df_cleaned[use_columns].apply(lambda x: x != 'UnKnown').sum(axis =1)\n",
    "df_cleaned.sort_values(by= 'total_uses',ascending = False).head(3)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c47c8904-3079-4b12-80dc-71e1fe020929",
   "metadata": {},
   "source": [
    "### Explore the most common uses of the medicines."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 368,
   "id": "a74b73c2-f5f5-4a60-98dc-85dcb76027bb",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>uses</th>\n",
       "      <th>uses_counts</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>549</th>\n",
       "      <td>Treatment of Bacterial infections</td>\n",
       "      <td>37129.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>313</th>\n",
       "      <td>Pain relief</td>\n",
       "      <td>21152.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>736</th>\n",
       "      <td>Treatment of Peptic ulcer disease</td>\n",
       "      <td>12581.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>627</th>\n",
       "      <td>Treatment of Gastroesophageal reflux disease (...</td>\n",
       "      <td>12556.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>799</th>\n",
       "      <td>Treatment of Type 2 diabetes mellitus</td>\n",
       "      <td>10250.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>Bacterial infections</td>\n",
       "      <td>9719.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>649</th>\n",
       "      <td>Treatment of Hypertension (high blood pressure)</td>\n",
       "      <td>7178.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>525</th>\n",
       "      <td>Treatment of Allergic conditions</td>\n",
       "      <td>5766.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>786</th>\n",
       "      <td>Treatment of Sneezing and runny nose due to al...</td>\n",
       "      <td>4904.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>637</th>\n",
       "      <td>Treatment of Heartburn</td>\n",
       "      <td>4381.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                  uses  uses_counts\n",
       "549                  Treatment of Bacterial infections      37129.0\n",
       "313                                        Pain relief      21152.0\n",
       "736                  Treatment of Peptic ulcer disease      12581.0\n",
       "627  Treatment of Gastroesophageal reflux disease (...      12556.0\n",
       "799              Treatment of Type 2 diabetes mellitus      10250.0\n",
       "41                                Bacterial infections       9719.0\n",
       "649    Treatment of Hypertension (high blood pressure)       7178.0\n",
       "525                   Treatment of Allergic conditions       5766.0\n",
       "786  Treatment of Sneezing and runny nose due to al...       4904.0\n",
       "637                             Treatment of Heartburn       4381.0"
      ]
     },
     "execution_count": 368,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Combine all use columns into one\n",
    "use_columns = [f'use{i}' for i in range(5)]\n",
    "\n",
    "uses = df_cleaned[use_columns].apply(lambda x: x.value_counts()).sum(axis =1)\n",
    "uses = pd.DataFrame(uses,columns = ['uses_counts']).reset_index()\n",
    "uses = uses.rename(columns = {'index':'uses'})\n",
    "\n",
    "# Filter out rows where 'uses' is \"Unknown\" or null\n",
    "uses = uses[uses.apply(lambda x: (x!= 'UnKnown'))]\n",
    "uses = uses.dropna()\n",
    "\n",
    "#sorting the dataframe\n",
    "uses = uses.sort_values(\"uses_counts\",ascending = False)\n",
    "\n",
    "#Top 10 using\n",
    "uses.head(10)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2d73f4af-aaf7-4639-a5e7-66b9ec365c82",
   "metadata": {},
   "source": [
    "### Explore 50 most used chemical  (Excluding 'Unknown')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 369,
   "id": "b9cb234f-feb8-4db0-a522-2125e978e1df",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Chemical Class\n",
       "Fluoroquinolone                                              7007\n",
       "Broad Spectrum (Third & fourth generation cephalosporins)    6407\n",
       "Macrolides                                                   4808\n",
       "Sulfinylbenzimidazole Derivative                             4395\n",
       "Broad spectrum (Third & fourth generation cephalosporins}    3936\n",
       "Gluco/mineralocorticoids, progestogins and derivatives       2604\n",
       "Azoles {Triazoles}                                           2443\n",
       "Intermediate spectrum {Second generation cephalosporins}     2375\n",
       "Carbazole Derivative                                         2278\n",
       "Glucocorticoids                                              2238\n",
       "Azole derivatives {Imidazoles}                               2065\n",
       "Benzodiazepines Derivative                                   2025\n",
       "Aminoglycosides                                              1951\n",
       "Piperazine Derivatives                                       1818\n",
       "P-Aminophenol Derivative                                     1563\n",
       "Aminopenicillins {Penicillins}                               1528\n",
       "Pyrrole & heptanoic acid derivative                          1505\n",
       "Anabolic steroid                                             1358\n",
       "Timoprazole Derivative                                       1327\n",
       "Phenylacetic acid Derivative                                 1304\n",
       "Progesterone Derivative                                      1263\n",
       "Sulfone and Pyridine Derivative                              1094\n",
       "Diphenylmethane Derivative                                   1035\n",
       "Carbapenem derivative                                        1011\n",
       "Cobalamin Derivative                                         1008\n",
       "Dihydropyridinecarboxylic acids derivatives                   966\n",
       "Phenylpyrimidine derivatives                                  947\n",
       "Histamine Analog                                              944\n",
       "Benzimidazole derivative                                      922\n",
       "Azoles derivatives                                            916\n",
       "Diphenylethers Derivative                                     845\n",
       "2-Benzimidazolylcarbamic acid esters                          790\n",
       "Phenylbutylamine Derivative                                   752\n",
       "Bile Acids and Salts                                          751\n",
       "Thienobenzodiazepine Derivative                               746\n",
       "Dichlorobenzenes Derivative                                   742\n",
       "Alcohol & phenols                                             718\n",
       "Piperazine Derivative                                         700\n",
       "Sesquiterpene lactones                                        680\n",
       "Biguanides Derivative                                         680\n",
       "Phenylmethyl Piperazinyl Derivative                           635\n",
       "Valiolamine derivative                                        584\n",
       "Pyrrolidinone & Acetamide Derivative                          559\n",
       "Dibenzocycloheptenes Derivative                               556\n",
       "Benzenesulfonamide Derivative                                 552\n",
       "Thiazole Derivative                                           540\n",
       "Narrow-spectrum {First generation cephalosporins}             539\n",
       "Oxazolidinone derivative                                      529\n",
       "Nucleoside analog                                             520\n",
       "Narrow- specttrum {First generation cephalosporins}           518\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 369,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_cleaned['Chemical Class'][df_cleaned['Chemical Class'].apply(lambda x:x!= 'UnKnown')].value_counts().head(50)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "94a3595c-d241-4c68-b0f5-9ac8a58fd8eb",
   "metadata": {},
   "source": [
    "### Explore the uses of Therapeutic class  (Excluding 'Unknown')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 370,
   "id": "ac6afe2e-57ec-48e5-a7d4-09c1965695bb",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Therapeutic Class\n",
       "ANTI INFECTIVES                50459\n",
       "GASTRO INTESTINAL              30442\n",
       "PAIN ANALGESICS                29187\n",
       "NEURO CNS                      21524\n",
       "RESPIRATORY                    21284\n",
       "CARDIAC                        16774\n",
       "ANTI DIABETIC                  10457\n",
       "OPHTHAL                         9494\n",
       "DERMA                           8949\n",
       "HORMONES                        4927\n",
       "GYNAECOLOGICAL                  4094\n",
       "VITAMINS MINERALS NUTRIENTS     3885\n",
       "ANTI NEOPLASTICS                3202\n",
       "BLOOD RELATED                   2464\n",
       "UROLOGY                         1720\n",
       "OPHTHAL OTOLOGICALS             1558\n",
       "ANTI MALARIALS                  1466\n",
       "SEX STIMULANTS REJUVENATORS      682\n",
       "OTHERS                           464\n",
       "OTOLOGICALS                      451\n",
       "VACCINES                         306\n",
       "STOMATOLOGICALS                  162\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 370,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_cleaned['Therapeutic Class'][df_cleaned['Therapeutic Class'].apply(lambda x:x!= 'UnKnown')].value_counts().sort_values(ascending = False)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "72492d24-e53b-4f57-9e9e-0d8246f64c25",
   "metadata": {},
   "source": [
    "### Explore the uses of Action class  (Excluding 'Unknown')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 371,
   "id": "e58af229-0e55-4f4f-84d8-07963773ac73",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Action Class\n",
       "Cephalosporins: 3 generation                               10901\n",
       "Quinolones/ Fluroquinolones                                 7011\n",
       "Fungal ergosterol synthesis inhibitor                       5990\n",
       "Proton pump inhibitors                                      5734\n",
       "Macrolides                                                  5109\n",
       "Glucocorticoids                                             4779\n",
       "H1 Antihistaminics (second Generation)                      3702\n",
       "HMG CoA inhibitors (statins)                                2561\n",
       "Cephalosporins: 2nd generation                              2448\n",
       "Benzodiazepines                                             2447\n",
       "NSAID's- Non-Selective COX 1&2 Inhibitors (acetic acid)     2426\n",
       "Serotonin antagonists (5-HT3 antagonists)                   2369\n",
       "Atypical Antipsychotics                                     2364\n",
       "Aminoglycosides                                             1951\n",
       "Selective Seretonin Reuptake inhibitors (SSRIs)             1829\n",
       "Angiotensin receptor blockers(ARB)                          1747\n",
       "Sodium channel modulators (AED)                             1600\n",
       "Analgesic & Antipyretic-PCM                                 1563\n",
       "Cell wall active agent -Extended spectrum Penicillin        1536\n",
       "Vitamins                                                    1364\n",
       "Anabolic steroid                                            1358\n",
       "Natural Progesterone                                        1263\n",
       "NSAID's -Selective COX-2 Inhibitors                         1213\n",
       "Beta blocker- Cardioselective                               1206\n",
       "Calcium channel blockers- Dihydropyridines (DHP)            1166\n",
       "Cephalosporins: 1st generation                              1057\n",
       "Cell wall active agent -Carbapenems                         1011\n",
       "Antiprotozoal agents                                         966\n",
       "Nootropic agent                                              944\n",
       "Histamine analog- Meniere's Disease                          944\n",
       "Sulfonylureas (Insulin Secretogogues)                        896\n",
       "NSAID's-Non-Selective COX 1&2 Inhibitors (Others)            872\n",
       "H1 Antihistaminics (First Generation)                        844\n",
       "Hepatoprotectives                                            837\n",
       "Antimalarial- Artemisinin and derivatives                    831\n",
       "Tricyclic antidepressants                                    779\n",
       "Synaptic vescicle 2 A protein ligand (AED)                   685\n",
       "Biguanides                                                   680\n",
       "Alpha-glucosidase inhibitors                                 679\n",
       "Xanthine oxidase Inhibitors-gout                             655\n",
       "DPP-4 inhibitors                                             648\n",
       "Theophylline & its derivatives                               610\n",
       "Ectoparasiticides                                            609\n",
       "Progestins (First generation)                                607\n",
       "Serotonin-norepinephrine reuptake inhibitors (SNRIs)         582\n",
       "Alpha 2 delta ligands (AED)                                  579\n",
       "Proteolytic Enzymes                                          578\n",
       "Angiotensin-converting enzyme (ACE) inhibitors               568\n",
       "Phosphodiesterase-V inhibitors                               564\n",
       "Oxazolidinone                                                529\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 371,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_cleaned['Action Class'][df_cleaned['Action Class'].apply(lambda x:x!= 'UnKnown')].value_counts().sort_values(ascending = False).head(50)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "30726275-a479-4c8d-bcf7-4c68c2eacf90",
   "metadata": {},
   "source": [
    "# Classification Analysis"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a5bf6b38-6074-4811-b820-97848644291b",
   "metadata": {},
   "source": [
    "### Top 50 Chemical Classes by Frequency of Medicines (Excluding 'Unknown')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 372,
   "id": "7f87e925-dd92-4808-879b-5d75ac3932e6",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Chemical Class\n",
       "Fluoroquinolone                                              7007\n",
       "Broad Spectrum (Third & fourth generation cephalosporins)    6407\n",
       "Macrolides                                                   4808\n",
       "Sulfinylbenzimidazole Derivative                             4395\n",
       "Broad spectrum (Third & fourth generation cephalosporins}    3936\n",
       "Gluco/mineralocorticoids, progestogins and derivatives       2604\n",
       "Azoles {Triazoles}                                           2443\n",
       "Intermediate spectrum {Second generation cephalosporins}     2375\n",
       "Carbazole Derivative                                         2278\n",
       "Glucocorticoids                                              2238\n",
       "Azole derivatives {Imidazoles}                               2065\n",
       "Benzodiazepines Derivative                                   2025\n",
       "Aminoglycosides                                              1951\n",
       "Piperazine Derivatives                                       1818\n",
       "P-Aminophenol Derivative                                     1563\n",
       "Aminopenicillins {Penicillins}                               1528\n",
       "Pyrrole & heptanoic acid derivative                          1505\n",
       "Anabolic steroid                                             1358\n",
       "Timoprazole Derivative                                       1327\n",
       "Phenylacetic acid Derivative                                 1304\n",
       "Progesterone Derivative                                      1263\n",
       "Sulfone and Pyridine Derivative                              1094\n",
       "Diphenylmethane Derivative                                   1035\n",
       "Carbapenem derivative                                        1011\n",
       "Cobalamin Derivative                                         1008\n",
       "Dihydropyridinecarboxylic acids derivatives                   966\n",
       "Phenylpyrimidine derivatives                                  947\n",
       "Histamine Analog                                              944\n",
       "Benzimidazole derivative                                      922\n",
       "Azoles derivatives                                            916\n",
       "Diphenylethers Derivative                                     845\n",
       "2-Benzimidazolylcarbamic acid esters                          790\n",
       "Phenylbutylamine Derivative                                   752\n",
       "Bile Acids and Salts                                          751\n",
       "Thienobenzodiazepine Derivative                               746\n",
       "Dichlorobenzenes Derivative                                   742\n",
       "Alcohol & phenols                                             718\n",
       "Piperazine Derivative                                         700\n",
       "Biguanides Derivative                                         680\n",
       "Sesquiterpene lactones                                        680\n",
       "Phenylmethyl Piperazinyl Derivative                           635\n",
       "Valiolamine derivative                                        584\n",
       "Pyrrolidinone & Acetamide Derivative                          559\n",
       "Dibenzocycloheptenes Derivative                               556\n",
       "Benzenesulfonamide Derivative                                 552\n",
       "Thiazole Derivative                                           540\n",
       "Narrow-spectrum {First generation cephalosporins}             539\n",
       "Oxazolidinone derivative                                      529\n",
       "Nucleoside analog                                             520\n",
       "Narrow- specttrum {First generation cephalosporins}           518\n",
       "Name: name, dtype: int64"
      ]
     },
     "execution_count": 372,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "med_frequency_by_chemical_class = df_cleaned.groupby('Chemical Class')['name'].count().loc[lambda x: x.index != \"UnKnown\"].sort_values(ascending=False)\n",
    "med_frequency_by_chemical_class.head(50)\n",
    "                                                                                                                                    "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1684bbb0-d065-48c9-8bbc-f67bb93c9861",
   "metadata": {},
   "source": [
    "### Top 50 Chemical Classes by Reported Side Effects Count (Excluding 'Unknown')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 373,
   "id": "01b52a81-d75c-4ae1-8799-03a54872e471",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Chemical Class\n",
       "Fluoroquinolone                                              294294\n",
       "Broad Spectrum (Third & fourth generation cephalosporins)    269094\n",
       "Macrolides                                                   201936\n",
       "Sulfinylbenzimidazole Derivative                             184590\n",
       "Broad spectrum (Third & fourth generation cephalosporins}    165312\n",
       "Gluco/mineralocorticoids, progestogins and derivatives       109368\n",
       "Azoles {Triazoles}                                           102606\n",
       "Intermediate spectrum {Second generation cephalosporins}      99750\n",
       "Carbazole Derivative                                          95676\n",
       "Glucocorticoids                                               93996\n",
       "Azole derivatives {Imidazoles}                                86730\n",
       "Benzodiazepines Derivative                                    85050\n",
       "Aminoglycosides                                               81942\n",
       "Piperazine Derivatives                                        76356\n",
       "P-Aminophenol Derivative                                      65646\n",
       "Aminopenicillins {Penicillins}                                64176\n",
       "Pyrrole & heptanoic acid derivative                           63210\n",
       "Anabolic steroid                                              57036\n",
       "Timoprazole Derivative                                        55734\n",
       "Phenylacetic acid Derivative                                  54768\n",
       "Progesterone Derivative                                       53046\n",
       "Sulfone and Pyridine Derivative                               45948\n",
       "Diphenylmethane Derivative                                    43470\n",
       "Carbapenem derivative                                         42462\n",
       "Cobalamin Derivative                                          42336\n",
       "Dihydropyridinecarboxylic acids derivatives                   40572\n",
       "Phenylpyrimidine derivatives                                  39774\n",
       "Histamine Analog                                              39648\n",
       "Benzimidazole derivative                                      38724\n",
       "Azoles derivatives                                            38472\n",
       "Diphenylethers Derivative                                     35490\n",
       "2-Benzimidazolylcarbamic acid esters                          33180\n",
       "Phenylbutylamine Derivative                                   31584\n",
       "Bile Acids and Salts                                          31542\n",
       "Thienobenzodiazepine Derivative                               31332\n",
       "Dichlorobenzenes Derivative                                   31164\n",
       "Alcohol & phenols                                             30156\n",
       "Piperazine Derivative                                         29400\n",
       "Biguanides Derivative                                         28560\n",
       "Sesquiterpene lactones                                        28560\n",
       "Phenylmethyl Piperazinyl Derivative                           26670\n",
       "Valiolamine derivative                                        24528\n",
       "Pyrrolidinone & Acetamide Derivative                          23478\n",
       "Dibenzocycloheptenes Derivative                               23352\n",
       "Benzenesulfonamide Derivative                                 23184\n",
       "Thiazole Derivative                                           22680\n",
       "Narrow-spectrum {First generation cephalosporins}             22638\n",
       "Oxazolidinone derivative                                      22218\n",
       "Nucleoside analog                                             21840\n",
       "Narrow- specttrum {First generation cephalosporins}           21756\n",
       "dtype: int64"
      ]
     },
     "execution_count": 373,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#loc[lambda x: x.index != \"UnKnown\"] excluding the index \"unknow\" from the result\n",
    "\n",
    "side_effect_frequency_by_chemical_class = df_cleaned.groupby(['Chemical Class'])[side_effect_columns].count().sum(axis = 1).loc[lambda x: x.index != 'UnKnown'].sort_values(ascending = False)\n",
    "side_effect_frequency_by_chemical_class.head(50)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "935fdff9-97cb-419b-8fde-426b0937c222",
   "metadata": {},
   "source": [
    "### Top 50 Chemical Classes by Usage Count Across All Use Columns (Excluding 'Unknown')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 374,
   "id": "13f26a9c-8c86-4329-aa4e-df1f7d2c34c0",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Chemical Class\n",
       "Fluoroquinolone                                              35035\n",
       "Broad Spectrum (Third & fourth generation cephalosporins)    32035\n",
       "Macrolides                                                   24040\n",
       "Sulfinylbenzimidazole Derivative                             21975\n",
       "Broad spectrum (Third & fourth generation cephalosporins}    19680\n",
       "Gluco/mineralocorticoids, progestogins and derivatives       13020\n",
       "Azoles {Triazoles}                                           12215\n",
       "Intermediate spectrum {Second generation cephalosporins}     11875\n",
       "Carbazole Derivative                                         11390\n",
       "Glucocorticoids                                              11190\n",
       "Azole derivatives {Imidazoles}                               10325\n",
       "Benzodiazepines Derivative                                   10125\n",
       "Aminoglycosides                                               9755\n",
       "Piperazine Derivatives                                        9090\n",
       "P-Aminophenol Derivative                                      7815\n",
       "Aminopenicillins {Penicillins}                                7640\n",
       "Pyrrole & heptanoic acid derivative                           7525\n",
       "Anabolic steroid                                              6790\n",
       "Timoprazole Derivative                                        6635\n",
       "Phenylacetic acid Derivative                                  6520\n",
       "Progesterone Derivative                                       6315\n",
       "Sulfone and Pyridine Derivative                               5470\n",
       "Diphenylmethane Derivative                                    5175\n",
       "Carbapenem derivative                                         5055\n",
       "Cobalamin Derivative                                          5040\n",
       "Dihydropyridinecarboxylic acids derivatives                   4830\n",
       "Phenylpyrimidine derivatives                                  4735\n",
       "Histamine Analog                                              4720\n",
       "Benzimidazole derivative                                      4610\n",
       "Azoles derivatives                                            4580\n",
       "Diphenylethers Derivative                                     4225\n",
       "2-Benzimidazolylcarbamic acid esters                          3950\n",
       "Phenylbutylamine Derivative                                   3760\n",
       "Bile Acids and Salts                                          3755\n",
       "Thienobenzodiazepine Derivative                               3730\n",
       "Dichlorobenzenes Derivative                                   3710\n",
       "Alcohol & phenols                                             3590\n",
       "Piperazine Derivative                                         3500\n",
       "Biguanides Derivative                                         3400\n",
       "Sesquiterpene lactones                                        3400\n",
       "Phenylmethyl Piperazinyl Derivative                           3175\n",
       "Valiolamine derivative                                        2920\n",
       "Pyrrolidinone & Acetamide Derivative                          2795\n",
       "Dibenzocycloheptenes Derivative                               2780\n",
       "Benzenesulfonamide Derivative                                 2760\n",
       "Thiazole Derivative                                           2700\n",
       "Narrow-spectrum {First generation cephalosporins}             2695\n",
       "Oxazolidinone derivative                                      2645\n",
       "Nucleoside analog                                             2600\n",
       "Narrow- specttrum {First generation cephalosporins}           2590\n",
       "dtype: int64"
      ]
     },
     "execution_count": 374,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "total_usage_frequency_by_chemical_class = df_cleaned.groupby(['Chemical Class'])[use_columns].count().sum(axis = 1).loc[lambda x: x.index != 'UnKnown'].sort_values(ascending = False)\n",
    "total_usage_frequency_by_chemical_class.head(50)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ff5f8c1c-a357-4de9-8952-f0f8673b7dd1",
   "metadata": {},
   "source": [
    "### Chemical Data Summary: Usage, Side Effects, and Total Frequency"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 375,
   "id": "09f031a6-720e-4a7a-ac3c-55c3335876ab",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Med_frequency</th>\n",
       "      <th>Side_effect_frequency</th>\n",
       "      <th>Total_usage_frequency</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Chemical Class</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>Fluoroquinolone</th>\n",
       "      <td>7007</td>\n",
       "      <td>294294</td>\n",
       "      <td>35035</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Broad Spectrum (Third &amp; fourth generation cephalosporins)</th>\n",
       "      <td>6407</td>\n",
       "      <td>269094</td>\n",
       "      <td>32035</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Macrolides</th>\n",
       "      <td>4808</td>\n",
       "      <td>201936</td>\n",
       "      <td>24040</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Sulfinylbenzimidazole Derivative</th>\n",
       "      <td>4395</td>\n",
       "      <td>184590</td>\n",
       "      <td>21975</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Broad spectrum (Third &amp; fourth generation cephalosporins}</th>\n",
       "      <td>3936</td>\n",
       "      <td>165312</td>\n",
       "      <td>19680</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Gluco/mineralocorticoids, progestogins and derivatives</th>\n",
       "      <td>2604</td>\n",
       "      <td>109368</td>\n",
       "      <td>13020</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Azoles {Triazoles}</th>\n",
       "      <td>2443</td>\n",
       "      <td>102606</td>\n",
       "      <td>12215</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Intermediate spectrum {Second generation cephalosporins}</th>\n",
       "      <td>2375</td>\n",
       "      <td>99750</td>\n",
       "      <td>11875</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Carbazole Derivative</th>\n",
       "      <td>2278</td>\n",
       "      <td>95676</td>\n",
       "      <td>11390</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Glucocorticoids</th>\n",
       "      <td>2238</td>\n",
       "      <td>93996</td>\n",
       "      <td>11190</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Azole derivatives {Imidazoles}</th>\n",
       "      <td>2065</td>\n",
       "      <td>86730</td>\n",
       "      <td>10325</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Benzodiazepines Derivative</th>\n",
       "      <td>2025</td>\n",
       "      <td>85050</td>\n",
       "      <td>10125</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Aminoglycosides</th>\n",
       "      <td>1951</td>\n",
       "      <td>81942</td>\n",
       "      <td>9755</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Piperazine Derivatives</th>\n",
       "      <td>1818</td>\n",
       "      <td>76356</td>\n",
       "      <td>9090</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>P-Aminophenol Derivative</th>\n",
       "      <td>1563</td>\n",
       "      <td>65646</td>\n",
       "      <td>7815</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Aminopenicillins {Penicillins}</th>\n",
       "      <td>1528</td>\n",
       "      <td>64176</td>\n",
       "      <td>7640</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Pyrrole &amp; heptanoic acid derivative</th>\n",
       "      <td>1505</td>\n",
       "      <td>63210</td>\n",
       "      <td>7525</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Anabolic steroid</th>\n",
       "      <td>1358</td>\n",
       "      <td>57036</td>\n",
       "      <td>6790</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Timoprazole Derivative</th>\n",
       "      <td>1327</td>\n",
       "      <td>55734</td>\n",
       "      <td>6635</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Phenylacetic acid Derivative</th>\n",
       "      <td>1304</td>\n",
       "      <td>54768</td>\n",
       "      <td>6520</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Progesterone Derivative</th>\n",
       "      <td>1263</td>\n",
       "      <td>53046</td>\n",
       "      <td>6315</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Sulfone and Pyridine Derivative</th>\n",
       "      <td>1094</td>\n",
       "      <td>45948</td>\n",
       "      <td>5470</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Diphenylmethane Derivative</th>\n",
       "      <td>1035</td>\n",
       "      <td>43470</td>\n",
       "      <td>5175</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Carbapenem derivative</th>\n",
       "      <td>1011</td>\n",
       "      <td>42462</td>\n",
       "      <td>5055</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Cobalamin Derivative</th>\n",
       "      <td>1008</td>\n",
       "      <td>42336</td>\n",
       "      <td>5040</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Dihydropyridinecarboxylic acids derivatives</th>\n",
       "      <td>966</td>\n",
       "      <td>40572</td>\n",
       "      <td>4830</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Phenylpyrimidine derivatives</th>\n",
       "      <td>947</td>\n",
       "      <td>39774</td>\n",
       "      <td>4735</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Histamine Analog</th>\n",
       "      <td>944</td>\n",
       "      <td>39648</td>\n",
       "      <td>4720</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Benzimidazole derivative</th>\n",
       "      <td>922</td>\n",
       "      <td>38724</td>\n",
       "      <td>4610</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Azoles derivatives</th>\n",
       "      <td>916</td>\n",
       "      <td>38472</td>\n",
       "      <td>4580</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Diphenylethers Derivative</th>\n",
       "      <td>845</td>\n",
       "      <td>35490</td>\n",
       "      <td>4225</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2-Benzimidazolylcarbamic acid esters</th>\n",
       "      <td>790</td>\n",
       "      <td>33180</td>\n",
       "      <td>3950</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Phenylbutylamine Derivative</th>\n",
       "      <td>752</td>\n",
       "      <td>31584</td>\n",
       "      <td>3760</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Bile Acids and Salts</th>\n",
       "      <td>751</td>\n",
       "      <td>31542</td>\n",
       "      <td>3755</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Thienobenzodiazepine Derivative</th>\n",
       "      <td>746</td>\n",
       "      <td>31332</td>\n",
       "      <td>3730</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Dichlorobenzenes Derivative</th>\n",
       "      <td>742</td>\n",
       "      <td>31164</td>\n",
       "      <td>3710</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Alcohol &amp; phenols</th>\n",
       "      <td>718</td>\n",
       "      <td>30156</td>\n",
       "      <td>3590</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Piperazine Derivative</th>\n",
       "      <td>700</td>\n",
       "      <td>29400</td>\n",
       "      <td>3500</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Biguanides Derivative</th>\n",
       "      <td>680</td>\n",
       "      <td>28560</td>\n",
       "      <td>3400</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Sesquiterpene lactones</th>\n",
       "      <td>680</td>\n",
       "      <td>28560</td>\n",
       "      <td>3400</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Phenylmethyl Piperazinyl Derivative</th>\n",
       "      <td>635</td>\n",
       "      <td>26670</td>\n",
       "      <td>3175</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Valiolamine derivative</th>\n",
       "      <td>584</td>\n",
       "      <td>24528</td>\n",
       "      <td>2920</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Pyrrolidinone &amp; Acetamide Derivative</th>\n",
       "      <td>559</td>\n",
       "      <td>23478</td>\n",
       "      <td>2795</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Dibenzocycloheptenes Derivative</th>\n",
       "      <td>556</td>\n",
       "      <td>23352</td>\n",
       "      <td>2780</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Benzenesulfonamide Derivative</th>\n",
       "      <td>552</td>\n",
       "      <td>23184</td>\n",
       "      <td>2760</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Thiazole Derivative</th>\n",
       "      <td>540</td>\n",
       "      <td>22680</td>\n",
       "      <td>2700</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Narrow-spectrum {First generation cephalosporins}</th>\n",
       "      <td>539</td>\n",
       "      <td>22638</td>\n",
       "      <td>2695</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Oxazolidinone derivative</th>\n",
       "      <td>529</td>\n",
       "      <td>22218</td>\n",
       "      <td>2645</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Nucleoside analog</th>\n",
       "      <td>520</td>\n",
       "      <td>21840</td>\n",
       "      <td>2600</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Narrow- specttrum {First generation cephalosporins}</th>\n",
       "      <td>518</td>\n",
       "      <td>21756</td>\n",
       "      <td>2590</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                    Med_frequency  \\\n",
       "Chemical Class                                                      \n",
       "Fluoroquinolone                                              7007   \n",
       "Broad Spectrum (Third & fourth generation cepha...           6407   \n",
       "Macrolides                                                   4808   \n",
       "Sulfinylbenzimidazole Derivative                             4395   \n",
       "Broad spectrum (Third & fourth generation cepha...           3936   \n",
       "Gluco/mineralocorticoids, progestogins and deri...           2604   \n",
       "Azoles {Triazoles}                                           2443   \n",
       "Intermediate spectrum {Second generation cephal...           2375   \n",
       "Carbazole Derivative                                         2278   \n",
       "Glucocorticoids                                              2238   \n",
       "Azole derivatives {Imidazoles}                               2065   \n",
       "Benzodiazepines Derivative                                   2025   \n",
       "Aminoglycosides                                              1951   \n",
       "Piperazine Derivatives                                       1818   \n",
       "P-Aminophenol Derivative                                     1563   \n",
       "Aminopenicillins {Penicillins}                               1528   \n",
       "Pyrrole & heptanoic acid derivative                          1505   \n",
       "Anabolic steroid                                             1358   \n",
       "Timoprazole Derivative                                       1327   \n",
       "Phenylacetic acid Derivative                                 1304   \n",
       "Progesterone Derivative                                      1263   \n",
       "Sulfone and Pyridine Derivative                              1094   \n",
       "Diphenylmethane Derivative                                   1035   \n",
       "Carbapenem derivative                                        1011   \n",
       "Cobalamin Derivative                                         1008   \n",
       "Dihydropyridinecarboxylic acids derivatives                   966   \n",
       "Phenylpyrimidine derivatives                                  947   \n",
       "Histamine Analog                                              944   \n",
       "Benzimidazole derivative                                      922   \n",
       "Azoles derivatives                                            916   \n",
       "Diphenylethers Derivative                                     845   \n",
       "2-Benzimidazolylcarbamic acid esters                          790   \n",
       "Phenylbutylamine Derivative                                   752   \n",
       "Bile Acids and Salts                                          751   \n",
       "Thienobenzodiazepine Derivative                               746   \n",
       "Dichlorobenzenes Derivative                                   742   \n",
       "Alcohol & phenols                                             718   \n",
       "Piperazine Derivative                                         700   \n",
       "Biguanides Derivative                                         680   \n",
       "Sesquiterpene lactones                                        680   \n",
       "Phenylmethyl Piperazinyl Derivative                           635   \n",
       "Valiolamine derivative                                        584   \n",
       "Pyrrolidinone & Acetamide Derivative                          559   \n",
       "Dibenzocycloheptenes Derivative                               556   \n",
       "Benzenesulfonamide Derivative                                 552   \n",
       "Thiazole Derivative                                           540   \n",
       "Narrow-spectrum {First generation cephalosporins}             539   \n",
       "Oxazolidinone derivative                                      529   \n",
       "Nucleoside analog                                             520   \n",
       "Narrow- specttrum {First generation cephalospor...            518   \n",
       "\n",
       "                                                    Side_effect_frequency  \\\n",
       "Chemical Class                                                              \n",
       "Fluoroquinolone                                                    294294   \n",
       "Broad Spectrum (Third & fourth generation cepha...                 269094   \n",
       "Macrolides                                                         201936   \n",
       "Sulfinylbenzimidazole Derivative                                   184590   \n",
       "Broad spectrum (Third & fourth generation cepha...                 165312   \n",
       "Gluco/mineralocorticoids, progestogins and deri...                 109368   \n",
       "Azoles {Triazoles}                                                 102606   \n",
       "Intermediate spectrum {Second generation cephal...                  99750   \n",
       "Carbazole Derivative                                                95676   \n",
       "Glucocorticoids                                                     93996   \n",
       "Azole derivatives {Imidazoles}                                      86730   \n",
       "Benzodiazepines Derivative                                          85050   \n",
       "Aminoglycosides                                                     81942   \n",
       "Piperazine Derivatives                                              76356   \n",
       "P-Aminophenol Derivative                                            65646   \n",
       "Aminopenicillins {Penicillins}                                      64176   \n",
       "Pyrrole & heptanoic acid derivative                                 63210   \n",
       "Anabolic steroid                                                    57036   \n",
       "Timoprazole Derivative                                              55734   \n",
       "Phenylacetic acid Derivative                                        54768   \n",
       "Progesterone Derivative                                             53046   \n",
       "Sulfone and Pyridine Derivative                                     45948   \n",
       "Diphenylmethane Derivative                                          43470   \n",
       "Carbapenem derivative                                               42462   \n",
       "Cobalamin Derivative                                                42336   \n",
       "Dihydropyridinecarboxylic acids derivatives                         40572   \n",
       "Phenylpyrimidine derivatives                                        39774   \n",
       "Histamine Analog                                                    39648   \n",
       "Benzimidazole derivative                                            38724   \n",
       "Azoles derivatives                                                  38472   \n",
       "Diphenylethers Derivative                                           35490   \n",
       "2-Benzimidazolylcarbamic acid esters                                33180   \n",
       "Phenylbutylamine Derivative                                         31584   \n",
       "Bile Acids and Salts                                                31542   \n",
       "Thienobenzodiazepine Derivative                                     31332   \n",
       "Dichlorobenzenes Derivative                                         31164   \n",
       "Alcohol & phenols                                                   30156   \n",
       "Piperazine Derivative                                               29400   \n",
       "Biguanides Derivative                                               28560   \n",
       "Sesquiterpene lactones                                              28560   \n",
       "Phenylmethyl Piperazinyl Derivative                                 26670   \n",
       "Valiolamine derivative                                              24528   \n",
       "Pyrrolidinone & Acetamide Derivative                                23478   \n",
       "Dibenzocycloheptenes Derivative                                     23352   \n",
       "Benzenesulfonamide Derivative                                       23184   \n",
       "Thiazole Derivative                                                 22680   \n",
       "Narrow-spectrum {First generation cephalosporins}                   22638   \n",
       "Oxazolidinone derivative                                            22218   \n",
       "Nucleoside analog                                                   21840   \n",
       "Narrow- specttrum {First generation cephalospor...                  21756   \n",
       "\n",
       "                                                    Total_usage_frequency  \n",
       "Chemical Class                                                             \n",
       "Fluoroquinolone                                                     35035  \n",
       "Broad Spectrum (Third & fourth generation cepha...                  32035  \n",
       "Macrolides                                                          24040  \n",
       "Sulfinylbenzimidazole Derivative                                    21975  \n",
       "Broad spectrum (Third & fourth generation cepha...                  19680  \n",
       "Gluco/mineralocorticoids, progestogins and deri...                  13020  \n",
       "Azoles {Triazoles}                                                  12215  \n",
       "Intermediate spectrum {Second generation cephal...                  11875  \n",
       "Carbazole Derivative                                                11390  \n",
       "Glucocorticoids                                                     11190  \n",
       "Azole derivatives {Imidazoles}                                      10325  \n",
       "Benzodiazepines Derivative                                          10125  \n",
       "Aminoglycosides                                                      9755  \n",
       "Piperazine Derivatives                                               9090  \n",
       "P-Aminophenol Derivative                                             7815  \n",
       "Aminopenicillins {Penicillins}                                       7640  \n",
       "Pyrrole & heptanoic acid derivative                                  7525  \n",
       "Anabolic steroid                                                     6790  \n",
       "Timoprazole Derivative                                               6635  \n",
       "Phenylacetic acid Derivative                                         6520  \n",
       "Progesterone Derivative                                              6315  \n",
       "Sulfone and Pyridine Derivative                                      5470  \n",
       "Diphenylmethane Derivative                                           5175  \n",
       "Carbapenem derivative                                                5055  \n",
       "Cobalamin Derivative                                                 5040  \n",
       "Dihydropyridinecarboxylic acids derivatives                          4830  \n",
       "Phenylpyrimidine derivatives                                         4735  \n",
       "Histamine Analog                                                     4720  \n",
       "Benzimidazole derivative                                             4610  \n",
       "Azoles derivatives                                                   4580  \n",
       "Diphenylethers Derivative                                            4225  \n",
       "2-Benzimidazolylcarbamic acid esters                                 3950  \n",
       "Phenylbutylamine Derivative                                          3760  \n",
       "Bile Acids and Salts                                                 3755  \n",
       "Thienobenzodiazepine Derivative                                      3730  \n",
       "Dichlorobenzenes Derivative                                          3710  \n",
       "Alcohol & phenols                                                    3590  \n",
       "Piperazine Derivative                                                3500  \n",
       "Biguanides Derivative                                                3400  \n",
       "Sesquiterpene lactones                                               3400  \n",
       "Phenylmethyl Piperazinyl Derivative                                  3175  \n",
       "Valiolamine derivative                                               2920  \n",
       "Pyrrolidinone & Acetamide Derivative                                 2795  \n",
       "Dibenzocycloheptenes Derivative                                      2780  \n",
       "Benzenesulfonamide Derivative                                        2760  \n",
       "Thiazole Derivative                                                  2700  \n",
       "Narrow-spectrum {First generation cephalosporins}                    2695  \n",
       "Oxazolidinone derivative                                             2645  \n",
       "Nucleoside analog                                                    2600  \n",
       "Narrow- specttrum {First generation cephalospor...                   2590  "
      ]
     },
     "execution_count": 375,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "all_abt_chemicals = pd.DataFrame({'Med_frequency': med_frequency_by_chemical_class, 'Side_effect_frequency': side_effect_frequency_by_chemical_class, 'Total_usage_frequency': total_usage_frequency_by_chemical_class})\n",
    "all_abt_chemicals.head(50)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "50f779f6-26bd-445a-8196-53a833680555",
   "metadata": {},
   "source": [
    "### Top 50 Action Classes by Frequency of Medicines (Excluding 'Unknown')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 376,
   "id": "638cdbe5-c256-4cb6-8aa3-cf6a3b40cf4b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Action Class\n",
       "Cephalosporins: 3 generation                               10901\n",
       "Quinolones/ Fluroquinolones                                 7011\n",
       "Fungal ergosterol synthesis inhibitor                       5990\n",
       "Proton pump inhibitors                                      5734\n",
       "Macrolides                                                  5109\n",
       "Glucocorticoids                                             4779\n",
       "H1 Antihistaminics (second Generation)                      3702\n",
       "HMG CoA inhibitors (statins)                                2561\n",
       "Cephalosporins: 2nd generation                              2448\n",
       "Benzodiazepines                                             2447\n",
       "NSAID's- Non-Selective COX 1&2 Inhibitors (acetic acid)     2426\n",
       "Serotonin antagonists (5-HT3 antagonists)                   2369\n",
       "Atypical Antipsychotics                                     2364\n",
       "Aminoglycosides                                             1951\n",
       "Selective Seretonin Reuptake inhibitors (SSRIs)             1829\n",
       "Angiotensin receptor blockers(ARB)                          1747\n",
       "Sodium channel modulators (AED)                             1600\n",
       "Analgesic & Antipyretic-PCM                                 1563\n",
       "Cell wall active agent -Extended spectrum Penicillin        1536\n",
       "Vitamins                                                    1364\n",
       "Anabolic steroid                                            1358\n",
       "Natural Progesterone                                        1263\n",
       "NSAID's -Selective COX-2 Inhibitors                         1213\n",
       "Beta blocker- Cardioselective                               1206\n",
       "Calcium channel blockers- Dihydropyridines (DHP)            1166\n",
       "Cephalosporins: 1st generation                              1057\n",
       "Cell wall active agent -Carbapenems                         1011\n",
       "Antiprotozoal agents                                         966\n",
       "Histamine analog- Meniere's Disease                          944\n",
       "Nootropic agent                                              944\n",
       "Sulfonylureas (Insulin Secretogogues)                        896\n",
       "NSAID's-Non-Selective COX 1&2 Inhibitors (Others)            872\n",
       "H1 Antihistaminics (First Generation)                        844\n",
       "Hepatoprotectives                                            837\n",
       "Antimalarial- Artemisinin and derivatives                    831\n",
       "Tricyclic antidepressants                                    779\n",
       "Synaptic vescicle 2 A protein ligand (AED)                   685\n",
       "Biguanides                                                   680\n",
       "Alpha-glucosidase inhibitors                                 679\n",
       "Xanthine oxidase Inhibitors-gout                             655\n",
       "DPP-4 inhibitors                                             648\n",
       "Theophylline & its derivatives                               610\n",
       "Ectoparasiticides                                            609\n",
       "Progestins (First generation)                                607\n",
       "Serotonin-norepinephrine reuptake inhibitors (SNRIs)         582\n",
       "Alpha 2 delta ligands (AED)                                  579\n",
       "Proteolytic Enzymes                                          578\n",
       "Angiotensin-converting enzyme (ACE) inhibitors               568\n",
       "Phosphodiesterase-V inhibitors                               564\n",
       "Oxazolidinone                                                529\n",
       "Name: name, dtype: int64"
      ]
     },
     "execution_count": 376,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "med_frequency_by_action_class = df_cleaned.groupby(['Action Class'])['name'].count().loc[lambda x: x.index != \"UnKnown\"].sort_values(ascending = False)\n",
    "med_frequency_by_action_class.head(50)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "99070324-d808-4a1c-a0c5-fb3f63e73110",
   "metadata": {},
   "source": [
    "### Top 50 ACtion Classes by Reported Side Effects Count (Excluding 'Unknown')¶"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 377,
   "id": "a1c4a62c-fc25-44af-8c38-bbece32173e1",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Action Class\n",
       "Cephalosporins: 3 generation                               457842\n",
       "Quinolones/ Fluroquinolones                                294462\n",
       "Fungal ergosterol synthesis inhibitor                      251580\n",
       "Proton pump inhibitors                                     240828\n",
       "Macrolides                                                 214578\n",
       "Glucocorticoids                                            200718\n",
       "H1 Antihistaminics (second Generation)                     155484\n",
       "HMG CoA inhibitors (statins)                               107562\n",
       "Cephalosporins: 2nd generation                             102816\n",
       "Benzodiazepines                                            102774\n",
       "NSAID's- Non-Selective COX 1&2 Inhibitors (acetic acid)    101892\n",
       "Serotonin antagonists (5-HT3 antagonists)                   99498\n",
       "Atypical Antipsychotics                                     99288\n",
       "Aminoglycosides                                             81942\n",
       "Selective Seretonin Reuptake inhibitors (SSRIs)             76818\n",
       "Angiotensin receptor blockers(ARB)                          73374\n",
       "Sodium channel modulators (AED)                             67200\n",
       "Analgesic & Antipyretic-PCM                                 65646\n",
       "Cell wall active agent -Extended spectrum Penicillin        64512\n",
       "Vitamins                                                    57288\n",
       "Anabolic steroid                                            57036\n",
       "Natural Progesterone                                        53046\n",
       "NSAID's -Selective COX-2 Inhibitors                         50946\n",
       "Beta blocker- Cardioselective                               50652\n",
       "Calcium channel blockers- Dihydropyridines (DHP)            48972\n",
       "Cephalosporins: 1st generation                              44394\n",
       "Cell wall active agent -Carbapenems                         42462\n",
       "Antiprotozoal agents                                        40572\n",
       "Histamine analog- Meniere's Disease                         39648\n",
       "Nootropic agent                                             39648\n",
       "Sulfonylureas (Insulin Secretogogues)                       37632\n",
       "NSAID's-Non-Selective COX 1&2 Inhibitors (Others)           36624\n",
       "H1 Antihistaminics (First Generation)                       35448\n",
       "Hepatoprotectives                                           35154\n",
       "Antimalarial- Artemisinin and derivatives                   34902\n",
       "Tricyclic antidepressants                                   32718\n",
       "Synaptic vescicle 2 A protein ligand (AED)                  28770\n",
       "Biguanides                                                  28560\n",
       "Alpha-glucosidase inhibitors                                28518\n",
       "Xanthine oxidase Inhibitors-gout                            27510\n",
       "DPP-4 inhibitors                                            27216\n",
       "Theophylline & its derivatives                              25620\n",
       "Ectoparasiticides                                           25578\n",
       "Progestins (First generation)                               25494\n",
       "Serotonin-norepinephrine reuptake inhibitors (SNRIs)        24444\n",
       "Alpha 2 delta ligands (AED)                                 24318\n",
       "Proteolytic Enzymes                                         24276\n",
       "Angiotensin-converting enzyme (ACE) inhibitors              23856\n",
       "Phosphodiesterase-V inhibitors                              23688\n",
       "Oxazolidinone                                               22218\n",
       "dtype: int64"
      ]
     },
     "execution_count": 377,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "side_effect_frequency_by_action_class =df_cleaned.groupby(['Action Class'])[side_effect_columns].count().sum(axis= 1).loc[lambda x: x.index != \"UnKnown\"].sort_values(ascending = False)\n",
    "side_effect_frequency_by_action_class.head(50)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ea9991a6-7845-4a26-82fb-d9f457e35679",
   "metadata": {},
   "source": [
    "### Top 50 Action Classes by Usage Count Across All Use Columns (Excluding 'Unknown')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 378,
   "id": "f6b7acac-4f1a-43a0-98a8-7fa71bf0bbcb",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Action Class\n",
       "Cephalosporins: 3 generation                               54505\n",
       "Quinolones/ Fluroquinolones                                35055\n",
       "Fungal ergosterol synthesis inhibitor                      29950\n",
       "Proton pump inhibitors                                     28670\n",
       "Macrolides                                                 25545\n",
       "Glucocorticoids                                            23895\n",
       "H1 Antihistaminics (second Generation)                     18510\n",
       "HMG CoA inhibitors (statins)                               12805\n",
       "Cephalosporins: 2nd generation                             12240\n",
       "Benzodiazepines                                            12235\n",
       "NSAID's- Non-Selective COX 1&2 Inhibitors (acetic acid)    12130\n",
       "Serotonin antagonists (5-HT3 antagonists)                  11845\n",
       "Atypical Antipsychotics                                    11820\n",
       "Aminoglycosides                                             9755\n",
       "Selective Seretonin Reuptake inhibitors (SSRIs)             9145\n",
       "Angiotensin receptor blockers(ARB)                          8735\n",
       "Sodium channel modulators (AED)                             8000\n",
       "Analgesic & Antipyretic-PCM                                 7815\n",
       "Cell wall active agent -Extended spectrum Penicillin        7680\n",
       "Vitamins                                                    6820\n",
       "Anabolic steroid                                            6790\n",
       "Natural Progesterone                                        6315\n",
       "NSAID's -Selective COX-2 Inhibitors                         6065\n",
       "Beta blocker- Cardioselective                               6030\n",
       "Calcium channel blockers- Dihydropyridines (DHP)            5830\n",
       "Cephalosporins: 1st generation                              5285\n",
       "Cell wall active agent -Carbapenems                         5055\n",
       "Antiprotozoal agents                                        4830\n",
       "Histamine analog- Meniere's Disease                         4720\n",
       "Nootropic agent                                             4720\n",
       "Sulfonylureas (Insulin Secretogogues)                       4480\n",
       "NSAID's-Non-Selective COX 1&2 Inhibitors (Others)           4360\n",
       "H1 Antihistaminics (First Generation)                       4220\n",
       "Hepatoprotectives                                           4185\n",
       "Antimalarial- Artemisinin and derivatives                   4155\n",
       "Tricyclic antidepressants                                   3895\n",
       "Synaptic vescicle 2 A protein ligand (AED)                  3425\n",
       "Biguanides                                                  3400\n",
       "Alpha-glucosidase inhibitors                                3395\n",
       "Xanthine oxidase Inhibitors-gout                            3275\n",
       "DPP-4 inhibitors                                            3240\n",
       "Theophylline & its derivatives                              3050\n",
       "Ectoparasiticides                                           3045\n",
       "Progestins (First generation)                               3035\n",
       "Serotonin-norepinephrine reuptake inhibitors (SNRIs)        2910\n",
       "Alpha 2 delta ligands (AED)                                 2895\n",
       "Proteolytic Enzymes                                         2890\n",
       "Angiotensin-converting enzyme (ACE) inhibitors              2840\n",
       "Phosphodiesterase-V inhibitors                              2820\n",
       "Oxazolidinone                                               2645\n",
       "dtype: int64"
      ]
     },
     "execution_count": 378,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "total_usage_frequency_by_action_class = df_cleaned.groupby(['Action Class'])[use_columns].count().sum(axis =1).loc[lambda x: x.index != 'UnKnown'].sort_values(ascending = False)\n",
    "total_usage_frequency_by_action_class.head(50)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7655f097-1cad-4b67-bb4a-d606ece6e9df",
   "metadata": {},
   "source": [
    "### Action Data Summary: Usage, Side Effects, and Total Frequency"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 379,
   "id": "2ea8cea6-8bd9-46c7-877f-873a21cc3af4",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Med_frequency</th>\n",
       "      <th>Side_effect_frequency</th>\n",
       "      <th>Total_usage_frequency</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Action Class</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>Cephalosporins: 3 generation</th>\n",
       "      <td>10901</td>\n",
       "      <td>457842</td>\n",
       "      <td>54505</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Quinolones/ Fluroquinolones</th>\n",
       "      <td>7011</td>\n",
       "      <td>294462</td>\n",
       "      <td>35055</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Fungal ergosterol synthesis inhibitor</th>\n",
       "      <td>5990</td>\n",
       "      <td>251580</td>\n",
       "      <td>29950</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Proton pump inhibitors</th>\n",
       "      <td>5734</td>\n",
       "      <td>240828</td>\n",
       "      <td>28670</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Macrolides</th>\n",
       "      <td>5109</td>\n",
       "      <td>214578</td>\n",
       "      <td>25545</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Glucocorticoids</th>\n",
       "      <td>4779</td>\n",
       "      <td>200718</td>\n",
       "      <td>23895</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>H1 Antihistaminics (second Generation)</th>\n",
       "      <td>3702</td>\n",
       "      <td>155484</td>\n",
       "      <td>18510</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>HMG CoA inhibitors (statins)</th>\n",
       "      <td>2561</td>\n",
       "      <td>107562</td>\n",
       "      <td>12805</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Cephalosporins: 2nd generation</th>\n",
       "      <td>2448</td>\n",
       "      <td>102816</td>\n",
       "      <td>12240</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Benzodiazepines</th>\n",
       "      <td>2447</td>\n",
       "      <td>102774</td>\n",
       "      <td>12235</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NSAID's- Non-Selective COX 1&amp;2 Inhibitors (acetic acid)</th>\n",
       "      <td>2426</td>\n",
       "      <td>101892</td>\n",
       "      <td>12130</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Serotonin antagonists (5-HT3 antagonists)</th>\n",
       "      <td>2369</td>\n",
       "      <td>99498</td>\n",
       "      <td>11845</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Atypical Antipsychotics</th>\n",
       "      <td>2364</td>\n",
       "      <td>99288</td>\n",
       "      <td>11820</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Aminoglycosides</th>\n",
       "      <td>1951</td>\n",
       "      <td>81942</td>\n",
       "      <td>9755</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Selective Seretonin Reuptake inhibitors (SSRIs)</th>\n",
       "      <td>1829</td>\n",
       "      <td>76818</td>\n",
       "      <td>9145</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Angiotensin receptor blockers(ARB)</th>\n",
       "      <td>1747</td>\n",
       "      <td>73374</td>\n",
       "      <td>8735</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Sodium channel modulators (AED)</th>\n",
       "      <td>1600</td>\n",
       "      <td>67200</td>\n",
       "      <td>8000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Analgesic &amp; Antipyretic-PCM</th>\n",
       "      <td>1563</td>\n",
       "      <td>65646</td>\n",
       "      <td>7815</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Cell wall active agent -Extended spectrum Penicillin</th>\n",
       "      <td>1536</td>\n",
       "      <td>64512</td>\n",
       "      <td>7680</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Vitamins</th>\n",
       "      <td>1364</td>\n",
       "      <td>57288</td>\n",
       "      <td>6820</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Anabolic steroid</th>\n",
       "      <td>1358</td>\n",
       "      <td>57036</td>\n",
       "      <td>6790</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Natural Progesterone</th>\n",
       "      <td>1263</td>\n",
       "      <td>53046</td>\n",
       "      <td>6315</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NSAID's -Selective COX-2 Inhibitors</th>\n",
       "      <td>1213</td>\n",
       "      <td>50946</td>\n",
       "      <td>6065</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Beta blocker- Cardioselective</th>\n",
       "      <td>1206</td>\n",
       "      <td>50652</td>\n",
       "      <td>6030</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Calcium channel blockers- Dihydropyridines (DHP)</th>\n",
       "      <td>1166</td>\n",
       "      <td>48972</td>\n",
       "      <td>5830</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Cephalosporins: 1st generation</th>\n",
       "      <td>1057</td>\n",
       "      <td>44394</td>\n",
       "      <td>5285</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Cell wall active agent -Carbapenems</th>\n",
       "      <td>1011</td>\n",
       "      <td>42462</td>\n",
       "      <td>5055</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Antiprotozoal agents</th>\n",
       "      <td>966</td>\n",
       "      <td>40572</td>\n",
       "      <td>4830</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Histamine analog- Meniere's Disease</th>\n",
       "      <td>944</td>\n",
       "      <td>39648</td>\n",
       "      <td>4720</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Nootropic agent</th>\n",
       "      <td>944</td>\n",
       "      <td>39648</td>\n",
       "      <td>4720</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Sulfonylureas (Insulin Secretogogues)</th>\n",
       "      <td>896</td>\n",
       "      <td>37632</td>\n",
       "      <td>4480</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NSAID's-Non-Selective COX 1&amp;2 Inhibitors (Others)</th>\n",
       "      <td>872</td>\n",
       "      <td>36624</td>\n",
       "      <td>4360</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>H1 Antihistaminics (First Generation)</th>\n",
       "      <td>844</td>\n",
       "      <td>35448</td>\n",
       "      <td>4220</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Hepatoprotectives</th>\n",
       "      <td>837</td>\n",
       "      <td>35154</td>\n",
       "      <td>4185</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Antimalarial- Artemisinin and derivatives</th>\n",
       "      <td>831</td>\n",
       "      <td>34902</td>\n",
       "      <td>4155</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Tricyclic antidepressants</th>\n",
       "      <td>779</td>\n",
       "      <td>32718</td>\n",
       "      <td>3895</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Synaptic vescicle 2 A protein ligand (AED)</th>\n",
       "      <td>685</td>\n",
       "      <td>28770</td>\n",
       "      <td>3425</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Biguanides</th>\n",
       "      <td>680</td>\n",
       "      <td>28560</td>\n",
       "      <td>3400</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Alpha-glucosidase inhibitors</th>\n",
       "      <td>679</td>\n",
       "      <td>28518</td>\n",
       "      <td>3395</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Xanthine oxidase Inhibitors-gout</th>\n",
       "      <td>655</td>\n",
       "      <td>27510</td>\n",
       "      <td>3275</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>DPP-4 inhibitors</th>\n",
       "      <td>648</td>\n",
       "      <td>27216</td>\n",
       "      <td>3240</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Theophylline &amp; its derivatives</th>\n",
       "      <td>610</td>\n",
       "      <td>25620</td>\n",
       "      <td>3050</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Ectoparasiticides</th>\n",
       "      <td>609</td>\n",
       "      <td>25578</td>\n",
       "      <td>3045</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Progestins (First generation)</th>\n",
       "      <td>607</td>\n",
       "      <td>25494</td>\n",
       "      <td>3035</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Serotonin-norepinephrine reuptake inhibitors (SNRIs)</th>\n",
       "      <td>582</td>\n",
       "      <td>24444</td>\n",
       "      <td>2910</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Alpha 2 delta ligands (AED)</th>\n",
       "      <td>579</td>\n",
       "      <td>24318</td>\n",
       "      <td>2895</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Proteolytic Enzymes</th>\n",
       "      <td>578</td>\n",
       "      <td>24276</td>\n",
       "      <td>2890</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Angiotensin-converting enzyme (ACE) inhibitors</th>\n",
       "      <td>568</td>\n",
       "      <td>23856</td>\n",
       "      <td>2840</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Phosphodiesterase-V inhibitors</th>\n",
       "      <td>564</td>\n",
       "      <td>23688</td>\n",
       "      <td>2820</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Oxazolidinone</th>\n",
       "      <td>529</td>\n",
       "      <td>22218</td>\n",
       "      <td>2645</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                    Med_frequency  \\\n",
       "Action Class                                                        \n",
       "Cephalosporins: 3 generation                                10901   \n",
       "Quinolones/ Fluroquinolones                                  7011   \n",
       "Fungal ergosterol synthesis inhibitor                        5990   \n",
       "Proton pump inhibitors                                       5734   \n",
       "Macrolides                                                   5109   \n",
       "Glucocorticoids                                              4779   \n",
       "H1 Antihistaminics (second Generation)                       3702   \n",
       "HMG CoA inhibitors (statins)                                 2561   \n",
       "Cephalosporins: 2nd generation                               2448   \n",
       "Benzodiazepines                                              2447   \n",
       "NSAID's- Non-Selective COX 1&2 Inhibitors (acet...           2426   \n",
       "Serotonin antagonists (5-HT3 antagonists)                    2369   \n",
       "Atypical Antipsychotics                                      2364   \n",
       "Aminoglycosides                                              1951   \n",
       "Selective Seretonin Reuptake inhibitors (SSRIs)              1829   \n",
       "Angiotensin receptor blockers(ARB)                           1747   \n",
       "Sodium channel modulators (AED)                              1600   \n",
       "Analgesic & Antipyretic-PCM                                  1563   \n",
       "Cell wall active agent -Extended spectrum Penic...           1536   \n",
       "Vitamins                                                     1364   \n",
       "Anabolic steroid                                             1358   \n",
       "Natural Progesterone                                         1263   \n",
       "NSAID's -Selective COX-2 Inhibitors                          1213   \n",
       "Beta blocker- Cardioselective                                1206   \n",
       "Calcium channel blockers- Dihydropyridines (DHP)             1166   \n",
       "Cephalosporins: 1st generation                               1057   \n",
       "Cell wall active agent -Carbapenems                          1011   \n",
       "Antiprotozoal agents                                          966   \n",
       "Histamine analog- Meniere's Disease                           944   \n",
       "Nootropic agent                                               944   \n",
       "Sulfonylureas (Insulin Secretogogues)                         896   \n",
       "NSAID's-Non-Selective COX 1&2 Inhibitors (Others)             872   \n",
       "H1 Antihistaminics (First Generation)                         844   \n",
       "Hepatoprotectives                                             837   \n",
       "Antimalarial- Artemisinin and derivatives                     831   \n",
       "Tricyclic antidepressants                                     779   \n",
       "Synaptic vescicle 2 A protein ligand (AED)                    685   \n",
       "Biguanides                                                    680   \n",
       "Alpha-glucosidase inhibitors                                  679   \n",
       "Xanthine oxidase Inhibitors-gout                              655   \n",
       "DPP-4 inhibitors                                              648   \n",
       "Theophylline & its derivatives                                610   \n",
       "Ectoparasiticides                                             609   \n",
       "Progestins (First generation)                                 607   \n",
       "Serotonin-norepinephrine reuptake inhibitors (S...            582   \n",
       "Alpha 2 delta ligands (AED)                                   579   \n",
       "Proteolytic Enzymes                                           578   \n",
       "Angiotensin-converting enzyme (ACE) inhibitors                568   \n",
       "Phosphodiesterase-V inhibitors                                564   \n",
       "Oxazolidinone                                                 529   \n",
       "\n",
       "                                                    Side_effect_frequency  \\\n",
       "Action Class                                                                \n",
       "Cephalosporins: 3 generation                                       457842   \n",
       "Quinolones/ Fluroquinolones                                        294462   \n",
       "Fungal ergosterol synthesis inhibitor                              251580   \n",
       "Proton pump inhibitors                                             240828   \n",
       "Macrolides                                                         214578   \n",
       "Glucocorticoids                                                    200718   \n",
       "H1 Antihistaminics (second Generation)                             155484   \n",
       "HMG CoA inhibitors (statins)                                       107562   \n",
       "Cephalosporins: 2nd generation                                     102816   \n",
       "Benzodiazepines                                                    102774   \n",
       "NSAID's- Non-Selective COX 1&2 Inhibitors (acet...                 101892   \n",
       "Serotonin antagonists (5-HT3 antagonists)                           99498   \n",
       "Atypical Antipsychotics                                             99288   \n",
       "Aminoglycosides                                                     81942   \n",
       "Selective Seretonin Reuptake inhibitors (SSRIs)                     76818   \n",
       "Angiotensin receptor blockers(ARB)                                  73374   \n",
       "Sodium channel modulators (AED)                                     67200   \n",
       "Analgesic & Antipyretic-PCM                                         65646   \n",
       "Cell wall active agent -Extended spectrum Penic...                  64512   \n",
       "Vitamins                                                            57288   \n",
       "Anabolic steroid                                                    57036   \n",
       "Natural Progesterone                                                53046   \n",
       "NSAID's -Selective COX-2 Inhibitors                                 50946   \n",
       "Beta blocker- Cardioselective                                       50652   \n",
       "Calcium channel blockers- Dihydropyridines (DHP)                    48972   \n",
       "Cephalosporins: 1st generation                                      44394   \n",
       "Cell wall active agent -Carbapenems                                 42462   \n",
       "Antiprotozoal agents                                                40572   \n",
       "Histamine analog- Meniere's Disease                                 39648   \n",
       "Nootropic agent                                                     39648   \n",
       "Sulfonylureas (Insulin Secretogogues)                               37632   \n",
       "NSAID's-Non-Selective COX 1&2 Inhibitors (Others)                   36624   \n",
       "H1 Antihistaminics (First Generation)                               35448   \n",
       "Hepatoprotectives                                                   35154   \n",
       "Antimalarial- Artemisinin and derivatives                           34902   \n",
       "Tricyclic antidepressants                                           32718   \n",
       "Synaptic vescicle 2 A protein ligand (AED)                          28770   \n",
       "Biguanides                                                          28560   \n",
       "Alpha-glucosidase inhibitors                                        28518   \n",
       "Xanthine oxidase Inhibitors-gout                                    27510   \n",
       "DPP-4 inhibitors                                                    27216   \n",
       "Theophylline & its derivatives                                      25620   \n",
       "Ectoparasiticides                                                   25578   \n",
       "Progestins (First generation)                                       25494   \n",
       "Serotonin-norepinephrine reuptake inhibitors (S...                  24444   \n",
       "Alpha 2 delta ligands (AED)                                         24318   \n",
       "Proteolytic Enzymes                                                 24276   \n",
       "Angiotensin-converting enzyme (ACE) inhibitors                      23856   \n",
       "Phosphodiesterase-V inhibitors                                      23688   \n",
       "Oxazolidinone                                                       22218   \n",
       "\n",
       "                                                    Total_usage_frequency  \n",
       "Action Class                                                               \n",
       "Cephalosporins: 3 generation                                        54505  \n",
       "Quinolones/ Fluroquinolones                                         35055  \n",
       "Fungal ergosterol synthesis inhibitor                               29950  \n",
       "Proton pump inhibitors                                              28670  \n",
       "Macrolides                                                          25545  \n",
       "Glucocorticoids                                                     23895  \n",
       "H1 Antihistaminics (second Generation)                              18510  \n",
       "HMG CoA inhibitors (statins)                                        12805  \n",
       "Cephalosporins: 2nd generation                                      12240  \n",
       "Benzodiazepines                                                     12235  \n",
       "NSAID's- Non-Selective COX 1&2 Inhibitors (acet...                  12130  \n",
       "Serotonin antagonists (5-HT3 antagonists)                           11845  \n",
       "Atypical Antipsychotics                                             11820  \n",
       "Aminoglycosides                                                      9755  \n",
       "Selective Seretonin Reuptake inhibitors (SSRIs)                      9145  \n",
       "Angiotensin receptor blockers(ARB)                                   8735  \n",
       "Sodium channel modulators (AED)                                      8000  \n",
       "Analgesic & Antipyretic-PCM                                          7815  \n",
       "Cell wall active agent -Extended spectrum Penic...                   7680  \n",
       "Vitamins                                                             6820  \n",
       "Anabolic steroid                                                     6790  \n",
       "Natural Progesterone                                                 6315  \n",
       "NSAID's -Selective COX-2 Inhibitors                                  6065  \n",
       "Beta blocker- Cardioselective                                        6030  \n",
       "Calcium channel blockers- Dihydropyridines (DHP)                     5830  \n",
       "Cephalosporins: 1st generation                                       5285  \n",
       "Cell wall active agent -Carbapenems                                  5055  \n",
       "Antiprotozoal agents                                                 4830  \n",
       "Histamine analog- Meniere's Disease                                  4720  \n",
       "Nootropic agent                                                      4720  \n",
       "Sulfonylureas (Insulin Secretogogues)                                4480  \n",
       "NSAID's-Non-Selective COX 1&2 Inhibitors (Others)                    4360  \n",
       "H1 Antihistaminics (First Generation)                                4220  \n",
       "Hepatoprotectives                                                    4185  \n",
       "Antimalarial- Artemisinin and derivatives                            4155  \n",
       "Tricyclic antidepressants                                            3895  \n",
       "Synaptic vescicle 2 A protein ligand (AED)                           3425  \n",
       "Biguanides                                                           3400  \n",
       "Alpha-glucosidase inhibitors                                         3395  \n",
       "Xanthine oxidase Inhibitors-gout                                     3275  \n",
       "DPP-4 inhibitors                                                     3240  \n",
       "Theophylline & its derivatives                                       3050  \n",
       "Ectoparasiticides                                                    3045  \n",
       "Progestins (First generation)                                        3035  \n",
       "Serotonin-norepinephrine reuptake inhibitors (S...                   2910  \n",
       "Alpha 2 delta ligands (AED)                                          2895  \n",
       "Proteolytic Enzymes                                                  2890  \n",
       "Angiotensin-converting enzyme (ACE) inhibitors                       2840  \n",
       "Phosphodiesterase-V inhibitors                                       2820  \n",
       "Oxazolidinone                                                        2645  "
      ]
     },
     "execution_count": 379,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "all_abt_action = pd.DataFrame({'Med_frequency': med_frequency_by_action_class, 'Side_effect_frequency': side_effect_frequency_by_action_class, 'Total_usage_frequency':total_usage_frequency_by_action_class})\n",
    "all_abt_action.head(50)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "dd2a53a0-b6b2-4c0c-a55f-43410bdf70c8",
   "metadata": {},
   "source": [
    "### Top 50 Therapeutic Classes by Frequency of Medicines (Excluding 'Unknown')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 380,
   "id": "a2d5647f-234b-4d1f-888d-efe48db831be",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Therapeutic Class\n",
       "ANTI INFECTIVES                50459\n",
       "GASTRO INTESTINAL              30442\n",
       "PAIN ANALGESICS                29187\n",
       "NEURO CNS                      21524\n",
       "RESPIRATORY                    21284\n",
       "CARDIAC                        16774\n",
       "ANTI DIABETIC                  10457\n",
       "OPHTHAL                         9494\n",
       "DERMA                           8949\n",
       "HORMONES                        4927\n",
       "GYNAECOLOGICAL                  4094\n",
       "VITAMINS MINERALS NUTRIENTS     3885\n",
       "ANTI NEOPLASTICS                3202\n",
       "BLOOD RELATED                   2464\n",
       "UROLOGY                         1720\n",
       "OPHTHAL OTOLOGICALS             1558\n",
       "ANTI MALARIALS                  1466\n",
       "SEX STIMULANTS REJUVENATORS      682\n",
       "OTHERS                           464\n",
       "OTOLOGICALS                      451\n",
       "VACCINES                         306\n",
       "STOMATOLOGICALS                  162\n",
       "Name: name, dtype: int64"
      ]
     },
     "execution_count": 380,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "med_frequency_by_Therapeutic_class =  df_cleaned.groupby(['Therapeutic Class'])['name'].count().loc[lambda x: x.index != 'UnKnown'].sort_values(ascending = False)\n",
    "med_frequency_by_Therapeutic_class.head(50)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e7183d4d-d032-4142-a0fa-4e03c926c22e",
   "metadata": {},
   "source": [
    "### Top 50 Therapeutic Classes by Reported Side Effects Count (Excluding 'Unknown')¶"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 381,
   "id": "1a69db38-ea27-4732-93dd-08590d701d37",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Therapeutic Class\n",
       "ANTI INFECTIVES                2119278\n",
       "GASTRO INTESTINAL              1278564\n",
       "PAIN ANALGESICS                1225854\n",
       "NEURO CNS                       904008\n",
       "RESPIRATORY                     893928\n",
       "CARDIAC                         704508\n",
       "ANTI DIABETIC                   439194\n",
       "OPHTHAL                         398748\n",
       "DERMA                           375858\n",
       "HORMONES                        206934\n",
       "GYNAECOLOGICAL                  171948\n",
       "VITAMINS MINERALS NUTRIENTS     163170\n",
       "ANTI NEOPLASTICS                134484\n",
       "BLOOD RELATED                   103488\n",
       "UROLOGY                          72240\n",
       "OPHTHAL OTOLOGICALS              65436\n",
       "ANTI MALARIALS                   61572\n",
       "SEX STIMULANTS REJUVENATORS      28644\n",
       "OTHERS                           19488\n",
       "OTOLOGICALS                      18942\n",
       "VACCINES                         12852\n",
       "STOMATOLOGICALS                   6804\n",
       "dtype: int64"
      ]
     },
     "execution_count": 381,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "side_effect_frequency_by_Therapeutic_class = df_cleaned.groupby(['Therapeutic Class'])[side_effect_columns].count().sum(axis =1).loc[lambda x: x.index != \"UnKnown\"].sort_values(ascending = False)\n",
    "side_effect_frequency_by_Therapeutic_class.head(50)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ffb2db17-6fa8-4794-ab86-a0d071e43d87",
   "metadata": {},
   "source": [
    "### Top 50 Therapeutic Classes by Usage Count Across All Use Columns (Excluding 'Unknown')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 382,
   "id": "8cdcff62-e03b-4c49-b110-bebf9f99f3c1",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Therapeutic Class\n",
       "ANTI INFECTIVES                252295\n",
       "GASTRO INTESTINAL              152210\n",
       "PAIN ANALGESICS                145935\n",
       "NEURO CNS                      107620\n",
       "RESPIRATORY                    106420\n",
       "CARDIAC                         83870\n",
       "ANTI DIABETIC                   52285\n",
       "OPHTHAL                         47470\n",
       "DERMA                           44745\n",
       "HORMONES                        24635\n",
       "GYNAECOLOGICAL                  20470\n",
       "VITAMINS MINERALS NUTRIENTS     19425\n",
       "ANTI NEOPLASTICS                16010\n",
       "BLOOD RELATED                   12320\n",
       "UROLOGY                          8600\n",
       "OPHTHAL OTOLOGICALS              7790\n",
       "ANTI MALARIALS                   7330\n",
       "SEX STIMULANTS REJUVENATORS      3410\n",
       "OTHERS                           2320\n",
       "OTOLOGICALS                      2255\n",
       "VACCINES                         1530\n",
       "STOMATOLOGICALS                   810\n",
       "dtype: int64"
      ]
     },
     "execution_count": 382,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "total_usage_frequency_by_Therapeutic_class = df_cleaned.groupby(['Therapeutic Class'])[use_columns].count().sum(axis =1).loc[lambda x:x.index != \"UnKnown\"].sort_values(ascending = False)\n",
    "total_usage_frequency_by_Therapeutic_class.head(50)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 383,
   "id": "d61803e6-3143-471c-8a4d-01f13c123c46",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Med_frequency</th>\n",
       "      <th>Side_effect_frequency</th>\n",
       "      <th>Total_usage_frequency</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Therapeutic Class</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>ANTI INFECTIVES</th>\n",
       "      <td>50459</td>\n",
       "      <td>2119278</td>\n",
       "      <td>252295</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>GASTRO INTESTINAL</th>\n",
       "      <td>30442</td>\n",
       "      <td>1278564</td>\n",
       "      <td>152210</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>PAIN ANALGESICS</th>\n",
       "      <td>29187</td>\n",
       "      <td>1225854</td>\n",
       "      <td>145935</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NEURO CNS</th>\n",
       "      <td>21524</td>\n",
       "      <td>904008</td>\n",
       "      <td>107620</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>RESPIRATORY</th>\n",
       "      <td>21284</td>\n",
       "      <td>893928</td>\n",
       "      <td>106420</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>CARDIAC</th>\n",
       "      <td>16774</td>\n",
       "      <td>704508</td>\n",
       "      <td>83870</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ANTI DIABETIC</th>\n",
       "      <td>10457</td>\n",
       "      <td>439194</td>\n",
       "      <td>52285</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>OPHTHAL</th>\n",
       "      <td>9494</td>\n",
       "      <td>398748</td>\n",
       "      <td>47470</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>DERMA</th>\n",
       "      <td>8949</td>\n",
       "      <td>375858</td>\n",
       "      <td>44745</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>HORMONES</th>\n",
       "      <td>4927</td>\n",
       "      <td>206934</td>\n",
       "      <td>24635</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>GYNAECOLOGICAL</th>\n",
       "      <td>4094</td>\n",
       "      <td>171948</td>\n",
       "      <td>20470</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>VITAMINS MINERALS NUTRIENTS</th>\n",
       "      <td>3885</td>\n",
       "      <td>163170</td>\n",
       "      <td>19425</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ANTI NEOPLASTICS</th>\n",
       "      <td>3202</td>\n",
       "      <td>134484</td>\n",
       "      <td>16010</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>BLOOD RELATED</th>\n",
       "      <td>2464</td>\n",
       "      <td>103488</td>\n",
       "      <td>12320</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>UROLOGY</th>\n",
       "      <td>1720</td>\n",
       "      <td>72240</td>\n",
       "      <td>8600</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>OPHTHAL OTOLOGICALS</th>\n",
       "      <td>1558</td>\n",
       "      <td>65436</td>\n",
       "      <td>7790</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ANTI MALARIALS</th>\n",
       "      <td>1466</td>\n",
       "      <td>61572</td>\n",
       "      <td>7330</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SEX STIMULANTS REJUVENATORS</th>\n",
       "      <td>682</td>\n",
       "      <td>28644</td>\n",
       "      <td>3410</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>OTHERS</th>\n",
       "      <td>464</td>\n",
       "      <td>19488</td>\n",
       "      <td>2320</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>OTOLOGICALS</th>\n",
       "      <td>451</td>\n",
       "      <td>18942</td>\n",
       "      <td>2255</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>VACCINES</th>\n",
       "      <td>306</td>\n",
       "      <td>12852</td>\n",
       "      <td>1530</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>STOMATOLOGICALS</th>\n",
       "      <td>162</td>\n",
       "      <td>6804</td>\n",
       "      <td>810</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                             Med_frequency  Side_effect_frequency  \\\n",
       "Therapeutic Class                                                   \n",
       "ANTI INFECTIVES                      50459                2119278   \n",
       "GASTRO INTESTINAL                    30442                1278564   \n",
       "PAIN ANALGESICS                      29187                1225854   \n",
       "NEURO CNS                            21524                 904008   \n",
       "RESPIRATORY                          21284                 893928   \n",
       "CARDIAC                              16774                 704508   \n",
       "ANTI DIABETIC                        10457                 439194   \n",
       "OPHTHAL                               9494                 398748   \n",
       "DERMA                                 8949                 375858   \n",
       "HORMONES                              4927                 206934   \n",
       "GYNAECOLOGICAL                        4094                 171948   \n",
       "VITAMINS MINERALS NUTRIENTS           3885                 163170   \n",
       "ANTI NEOPLASTICS                      3202                 134484   \n",
       "BLOOD RELATED                         2464                 103488   \n",
       "UROLOGY                               1720                  72240   \n",
       "OPHTHAL OTOLOGICALS                   1558                  65436   \n",
       "ANTI MALARIALS                        1466                  61572   \n",
       "SEX STIMULANTS REJUVENATORS            682                  28644   \n",
       "OTHERS                                 464                  19488   \n",
       "OTOLOGICALS                            451                  18942   \n",
       "VACCINES                               306                  12852   \n",
       "STOMATOLOGICALS                        162                   6804   \n",
       "\n",
       "                             Total_usage_frequency  \n",
       "Therapeutic Class                                   \n",
       "ANTI INFECTIVES                             252295  \n",
       "GASTRO INTESTINAL                           152210  \n",
       "PAIN ANALGESICS                             145935  \n",
       "NEURO CNS                                   107620  \n",
       "RESPIRATORY                                 106420  \n",
       "CARDIAC                                      83870  \n",
       "ANTI DIABETIC                                52285  \n",
       "OPHTHAL                                      47470  \n",
       "DERMA                                        44745  \n",
       "HORMONES                                     24635  \n",
       "GYNAECOLOGICAL                               20470  \n",
       "VITAMINS MINERALS NUTRIENTS                  19425  \n",
       "ANTI NEOPLASTICS                             16010  \n",
       "BLOOD RELATED                                12320  \n",
       "UROLOGY                                       8600  \n",
       "OPHTHAL OTOLOGICALS                           7790  \n",
       "ANTI MALARIALS                                7330  \n",
       "SEX STIMULANTS REJUVENATORS                   3410  \n",
       "OTHERS                                        2320  \n",
       "OTOLOGICALS                                   2255  \n",
       "VACCINES                                      1530  \n",
       "STOMATOLOGICALS                                810  "
      ]
     },
     "execution_count": 383,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "all_abt_Therapeutic_class = pd.DataFrame({'Med_frequency': med_frequency_by_Therapeutic_class, 'Side_effect_frequency': side_effect_frequency_by_Therapeutic_class, 'Total_usage_frequency':total_usage_frequency_by_Therapeutic_class})\n",
    "all_abt_Therapeutic_class.head(50)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8ac01a51-cfad-4b76-99a9-aa130a6daab4",
   "metadata": {},
   "source": [
    "### Creating Separate DataFrames for Drugs Based on Substitute Count"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3fbf1a02-d527-43d9-856f-abf14efa3673",
   "metadata": {},
   "source": [
    "df_cleaned[df_cleaned[substitute_columns].apply(lambda x: x != 'UnKnown').sum(axis =1)==5][['name','total_substitute_counts']]\n",
    "df_cleaned[df_cleaned[substitute_columns].apply(lambda x: x != 'UnKnown').sum(axis =1)==4][['name','total_substitute_counts']]\n",
    "df_cleaned[df_cleaned[substitute_columns].apply(lambda x: x != 'UnKnown').sum(axis =1)==3][['name','total_substitute_counts']]\n",
    "df_cleaned[df_cleaned[substitute_columns].apply(lambda x: x != 'UnKnown').sum(axis =1)==2][['name','total_substitute_counts']]\n",
    "df_cleaned[df_cleaned[substitute_columns].apply(lambda x: x != 'UnKnown').sum(axis =1)==1][['name','total_substitute_counts']]\n",
    "df_cleaned[df_cleaned[substitute_columns].apply(lambda x: x != 'UnKnown').sum(axis =1)==0][['name','total_substitute_counts']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 384,
   "id": "c64da893-e0a1-45dd-be20-da09f0933234",
   "metadata": {},
   "outputs": [],
   "source": [
    "for i in range( 6):\n",
    "    globals()[f\"substitute_{i}\"] = df_cleaned[df_cleaned[substitute_columns].apply(lambda x: x != 'UnKnown').sum(axis=1) == i][['name', 'total_substitute_counts']]\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 385,
   "id": "132c2970-8b70-4ab8-908c-be0904c57d8d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>name</th>\n",
       "      <th>total_substitute_counts</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>ambrodil-s syrup</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>72</th>\n",
       "      <td>aquasol a capsule</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>86</th>\n",
       "      <td>aerocort inhaler</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>93</th>\n",
       "      <td>atarax drops</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>antid 300mcg/ml injection</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                         name  total_substitute_counts\n",
       "14           ambrodil-s syrup                        0\n",
       "72          aquasol a capsule                        0\n",
       "86           aerocort inhaler                        0\n",
       "93               atarax drops                        0\n",
       "95  antid 300mcg/ml injection                        0"
      ]
     },
     "execution_count": 385,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#name of the medicine that has only 0 subsitute\n",
    "substitute_0.head(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 386,
   "id": "1ee87988-8186-47bc-8c14-832a8878b08d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>name</th>\n",
       "      <th>total_substitute_counts</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>avil 25 tablet</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>alkasol oral solution</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>108</th>\n",
       "      <td>alkasol oral solution sugar free</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>124</th>\n",
       "      <td>avanair 100 tablet</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>141</th>\n",
       "      <td>ambrolite-s expectorant</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                 name  total_substitute_counts\n",
       "4                      avil 25 tablet                        1\n",
       "35              alkasol oral solution                        1\n",
       "108  alkasol oral solution sugar free                        1\n",
       "124                avanair 100 tablet                        1\n",
       "141           ambrolite-s expectorant                        1"
      ]
     },
     "execution_count": 386,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#name of the medicine that has only 1 subsitute\n",
    "substitute_1.head(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 387,
   "id": "7db8144b-4661-4554-a64b-df730b24ab22",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>name</th>\n",
       "      <th>total_substitute_counts</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>alex cough lozenges lemon ginger</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>116</th>\n",
       "      <td>alerid-d tablet</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>147</th>\n",
       "      <td>adrenaline tartrate injection</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>161</th>\n",
       "      <td>addnok 0.2mg tablet</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>234</th>\n",
       "      <td>asthalin respirator solution</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                 name  total_substitute_counts\n",
       "53   alex cough lozenges lemon ginger                        2\n",
       "116                   alerid-d tablet                        2\n",
       "147     adrenaline tartrate injection                        2\n",
       "161               addnok 0.2mg tablet                        2\n",
       "234      asthalin respirator solution                        2"
      ]
     },
     "execution_count": 387,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#name of the medicine that has only 2 subsitute\n",
    "substitute_2.head(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 388,
   "id": "43c61cd7-bb64-4f6b-b5c0-f181b2a6c138",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>name</th>\n",
       "      <th>total_substitute_counts</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>anovate cream</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>63</th>\n",
       "      <td>af kit tablet</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>82</th>\n",
       "      <td>angispan - tr 2.5mg capsule</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123</th>\n",
       "      <td>ajaduo 25mg/5mg tablet</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>130</th>\n",
       "      <td>aldosmin 500mg tablet</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                            name  total_substitute_counts\n",
       "12                 anovate cream                        3\n",
       "63                 af kit tablet                        3\n",
       "82   angispan - tr 2.5mg capsule                        3\n",
       "123       ajaduo 25mg/5mg tablet                        3\n",
       "130        aldosmin 500mg tablet                        3"
      ]
     },
     "execution_count": 388,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#name of the medicine that has only 3 subsitute\n",
    "substitute_3.head(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 389,
   "id": "5898def3-b3a8-432e-9538-f4a2aca74674",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>name</th>\n",
       "      <th>total_substitute_counts</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>asthakind expectorant sugar free</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>asthalin respules</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>avil injection</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>133</th>\n",
       "      <td>af 150 tablet dt</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>138</th>\n",
       "      <td>amantrel tablet</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                 name  total_substitute_counts\n",
       "49   asthakind expectorant sugar free                        4\n",
       "54                  asthalin respules                        4\n",
       "55                     avil injection                        4\n",
       "133                  af 150 tablet dt                        4\n",
       "138                   amantrel tablet                        4"
      ]
     },
     "execution_count": 389,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#name of the medicine that has only 4 subsitute\n",
    "substitute_4.head(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 390,
   "id": "d950eaa4-396a-4742-b134-77a606b82641",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>name</th>\n",
       "      <th>total_substitute_counts</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>augmentin 625 duo tablet</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>azithral 500 tablet</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>ascoril ls syrup</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>allegra 120mg tablet</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>allegra-m tablet</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                       name  total_substitute_counts\n",
       "0  augmentin 625 duo tablet                        5\n",
       "1       azithral 500 tablet                        5\n",
       "2          ascoril ls syrup                        5\n",
       "3      allegra 120mg tablet                        5\n",
       "5          allegra-m tablet                        5"
      ]
     },
     "execution_count": 390,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#name of the medicine that has only 5 subsitute\n",
    "substitute_5.head(5)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d25084c4-248b-496d-ae1b-26d236f49333",
   "metadata": {},
   "source": [
    "### Count of Habit-Forming Drugs by Chemical Class"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 391,
   "id": "6daca600-8ef8-47ed-9b6d-dbb592971235",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Chemical Class</th>\n",
       "      <th>Habit-Forming Medications per Chemical Class</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Amphetamines Derivatives</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Anisole Derivative</td>\n",
       "      <td>365</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Aralkylamine Derivative</td>\n",
       "      <td>21</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Barbituric Acid Derivative</td>\n",
       "      <td>55</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Benzodiazepine Derivative</td>\n",
       "      <td>83</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Benzodiazepines Derivative</td>\n",
       "      <td>2025</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Benzomorphan Derivatives</td>\n",
       "      <td>20</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Cyclopyrrolone Derivative</td>\n",
       "      <td>28</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Diphenylmethane Derivative</td>\n",
       "      <td>49</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>Imidazopyridine Derivative</td>\n",
       "      <td>194</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>Phenanthrenes Derivative</td>\n",
       "      <td>22</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Phenanthrenes Derivatives</td>\n",
       "      <td>26</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>Phenylheptylamines Derivative</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>Phenylpiperidine Derivatives</td>\n",
       "      <td>12</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>Pyrazolopyrimidine Derivative</td>\n",
       "      <td>11</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>Ultrashort-Acting Barbituric Acid Derivative</td>\n",
       "      <td>11</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                  Chemical Class  \\\n",
       "0                       Amphetamines Derivatives   \n",
       "1                             Anisole Derivative   \n",
       "2                        Aralkylamine Derivative   \n",
       "3                     Barbituric Acid Derivative   \n",
       "4                      Benzodiazepine Derivative   \n",
       "5                     Benzodiazepines Derivative   \n",
       "6                       Benzomorphan Derivatives   \n",
       "7                      Cyclopyrrolone Derivative   \n",
       "8                     Diphenylmethane Derivative   \n",
       "9                     Imidazopyridine Derivative   \n",
       "10                      Phenanthrenes Derivative   \n",
       "11                     Phenanthrenes Derivatives   \n",
       "12                 Phenylheptylamines Derivative   \n",
       "13                  Phenylpiperidine Derivatives   \n",
       "14                 Pyrazolopyrimidine Derivative   \n",
       "15  Ultrashort-Acting Barbituric Acid Derivative   \n",
       "\n",
       "    Habit-Forming Medications per Chemical Class  \n",
       "0                                              6  \n",
       "1                                            365  \n",
       "2                                             21  \n",
       "3                                             55  \n",
       "4                                             83  \n",
       "5                                           2025  \n",
       "6                                             20  \n",
       "7                                             28  \n",
       "8                                             49  \n",
       "9                                            194  \n",
       "10                                            22  \n",
       "11                                            26  \n",
       "12                                             1  \n",
       "13                                            12  \n",
       "14                                            11  \n",
       "15                                            11  "
      ]
     },
     "execution_count": 391,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "habit_forming_counts_by_chemical_class = df_cleaned[df_cleaned['Habit Forming'] == 'Yes'].groupby(['Chemical Class'])['Habit Forming'].count().loc[lambda x:x.index != 'UnKnown']\n",
    "habit_forming_counts_by_chemical_class = pd.DataFrame(habit_forming_counts_by_chemical_class).reset_index()\n",
    "habit_forming_counts_by_chemical_class = habit_forming_counts_by_chemical_class.rename(columns = {'Habit Forming' : 'Habit-Forming Medications per Chemical Class'})\n",
    "habit_forming_counts_by_chemical_class"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 392,
   "id": "05e327dc-7623-4cc9-8719-2b7b09c26633",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Text(0.5, 0, 'Habit-Forming Medications Counts')"
      ]
     },
     "execution_count": 392,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x400 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure(figsize=(10,4))\n",
    "ax = sns.barplot(data=habit_forming_counts_by_chemical_class,y='Chemical Class',x='Habit-Forming Medications per Chemical Class',color='red')\n",
    "ax.bar_label(ax.containers[0], fontsize=6)\n",
    "plt.xlabel('Habit-Forming Medications Counts')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "149e2c54-6c32-4413-9549-98c16fa0a6e8",
   "metadata": {},
   "source": [
    "### Count of Habit-Forming Drugs by Action Class"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 393,
   "id": "8a0993d0-3f67-4a3f-9aad-edb035cbfd45",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Action Class</th>\n",
       "      <th>Habit-Forming Medications per Action Class</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Barbiturate</td>\n",
       "      <td>66</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Benzodiazepines</td>\n",
       "      <td>2108</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Non-benzodiazepine hypnotics (Z Compounds)</td>\n",
       "      <td>233</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Opioids</td>\n",
       "      <td>420</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Opioids- Partial agonist</td>\n",
       "      <td>26</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Stimulant/ Drug for excessive sleepiness</td>\n",
       "      <td>49</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Sympathomimetics agonist</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Sympthatomimmetics-ADHD</td>\n",
       "      <td>21</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                 Action Class  \\\n",
       "0                                 Barbiturate   \n",
       "1                             Benzodiazepines   \n",
       "2  Non-benzodiazepine hypnotics (Z Compounds)   \n",
       "3                                     Opioids   \n",
       "4                    Opioids- Partial agonist   \n",
       "5    Stimulant/ Drug for excessive sleepiness   \n",
       "6                    Sympathomimetics agonist   \n",
       "7                     Sympthatomimmetics-ADHD   \n",
       "\n",
       "   Habit-Forming Medications per Action Class  \n",
       "0                                          66  \n",
       "1                                        2108  \n",
       "2                                         233  \n",
       "3                                         420  \n",
       "4                                          26  \n",
       "5                                          49  \n",
       "6                                           6  \n",
       "7                                          21  "
      ]
     },
     "execution_count": 393,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "habit_forming_counts_by_action_class = df_cleaned[df_cleaned['Habit Forming'] == 'Yes'].groupby(['Action Class'])['Habit Forming'].count().loc[lambda x:x.index != 'UnKnown']\n",
    "habit_forming_counts_by_action_class = pd.DataFrame(habit_forming_counts_by_action_class).reset_index()\n",
    "habit_forming_counts_by_action_class = habit_forming_counts_by_action_class.rename(columns = {'Habit Forming' : 'Habit-Forming Medications per Action Class'})\n",
    "habit_forming_counts_by_action_class"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 394,
   "id": "9057d472-0b47-484c-89f5-d1f44100f91a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Text(0.5, 0, 'Habit-Forming Medications Counts')"
      ]
     },
     "execution_count": 394,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x400 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure(figsize=(10,4))\n",
    "ax = sns.barplot(data=habit_forming_counts_by_action_class,y='Action Class',x='Habit-Forming Medications per Action Class',color='red')\n",
    "ax.bar_label(ax.containers[0], fontsize=6)\n",
    "plt.xlabel('Habit-Forming Medications Counts')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1623752c-12d6-442e-a934-60ac4a92d74c",
   "metadata": {},
   "source": [
    "### Count of Habit-Forming Drugs by Therapeutic Class"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 395,
   "id": "54951a83-973e-446f-a047-9f2209198c2e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Therapeutic Class</th>\n",
       "      <th>Habit-Forming Medications per Therapeutic Class</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>CARDIAC</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>GASTRO INTESTINAL</td>\n",
       "      <td>223</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NEURO CNS</td>\n",
       "      <td>3676</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>PAIN ANALGESICS</td>\n",
       "      <td>1114</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>RESPIRATORY</td>\n",
       "      <td>442</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Therapeutic Class  Habit-Forming Medications per Therapeutic Class\n",
       "0            CARDIAC                                                6\n",
       "1  GASTRO INTESTINAL                                              223\n",
       "2          NEURO CNS                                             3676\n",
       "3    PAIN ANALGESICS                                             1114\n",
       "4        RESPIRATORY                                              442"
      ]
     },
     "execution_count": 395,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "habit_forming_counts_by_Therapeutic_class = df_cleaned[df_cleaned['Habit Forming'] == 'Yes'].groupby(['Therapeutic Class'])['Habit Forming'].count().loc[lambda x:x.index != 'UnKnown']\n",
    "habit_forming_counts_by_Therapeutic_class = pd.DataFrame(habit_forming_counts_by_Therapeutic_class).reset_index()\n",
    "habit_forming_counts_by_Therapeutic_class = habit_forming_counts_by_Therapeutic_class.rename(columns = {'Habit Forming' : 'Habit-Forming Medications per Therapeutic Class'})\n",
    "habit_forming_counts_by_Therapeutic_class"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 396,
   "id": "4dfb03dc-9c1c-413a-bdbd-5a657e84005c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Text(0.5, 0, 'Habit-Forming Medications Counts')"
      ]
     },
     "execution_count": 396,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x400 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure(figsize=(10,4))\n",
    "ax = sns.barplot(data=habit_forming_counts_by_Therapeutic_class,y='Therapeutic Class',x='Habit-Forming Medications per Therapeutic Class',color='red')\n",
    "ax.bar_label(ax.containers[0], fontsize=6)\n",
    "plt.xlabel('Habit-Forming Medications Counts')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ede9c1b1-f66e-4a96-befc-2e54804fd740",
   "metadata": {},
   "source": [
    "### Identify the medicine that has less than 5 Side Effects"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 397,
   "id": "98b7ee26-47d5-440f-b044-dc28fa755ceb",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>name</th>\n",
       "      <th>total_side_effect_recorded</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>augmentin 625 duo tablet</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>azithral 500 tablet</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>allegra 120mg tablet</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>avil 25 tablet</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>amoxyclav 625 tablet</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>248209</th>\n",
       "      <td>zef cv 200mg/125mg tablet</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>248210</th>\n",
       "      <td>ziyapod 100mg oral suspension</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>248215</th>\n",
       "      <td>zivex 25mg tablet</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>248216</th>\n",
       "      <td>zi fast 500mg injection</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>248217</th>\n",
       "      <td>zyvocol 1% dusting powder</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>104685 rows × 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                 name  total_side_effect_recorded\n",
       "0            augmentin 625 duo tablet                           3\n",
       "1                 azithral 500 tablet                           4\n",
       "3                allegra 120mg tablet                           4\n",
       "4                      avil 25 tablet                           2\n",
       "6                amoxyclav 625 tablet                           3\n",
       "...                               ...                         ...\n",
       "248209      zef cv 200mg/125mg tablet                           5\n",
       "248210  ziyapod 100mg oral suspension                           3\n",
       "248215              zivex 25mg tablet                           5\n",
       "248216        zi fast 500mg injection                           5\n",
       "248217      zyvocol 1% dusting powder                           4\n",
       "\n",
       "[104685 rows x 2 columns]"
      ]
     },
     "execution_count": 397,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_cleaned[df_cleaned['total_side_effect_recorded']<=5][['name','total_side_effect_recorded']]"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "00f0d695-a43c-458e-b8cf-78354fdd235e",
   "metadata": {},
   "source": [
    "### Discussion And Conclusion :\"250k Medicines Usage, Side Effects, and Substitutes\"\n",
    "\n",
    "### Project Overview:\n",
    "The goal of this project was to analyze a dataset that includes detailed information about over 250,000 medicines. This dataset covers attributes such as the drug names, their substitutes, side effects, therapeutic uses, chemical classes, and more. By analyzing this data, I aimed to identify patterns in medicine usage, common side effects, and the availability of substitutes, with the ultimate goal of gaining insights that can be useful in pharmaceutical research, healthcare, and drug safety.\n",
    "\n",
    "### Step-by-Step Analysis:\n",
    "\n",
    "1. **Data Loading and Initial Exploration**:\n",
    "   I started by loading the dataset using Python (with Pandas) and conducted an initial inspection. This step involved:\n",
    "   - Checking the basic structure of the dataset.\n",
    "   - Identifying columns and their data types.\n",
    "   - Reviewing the first few rows to get a sense of the data.\n",
    "\n",
    "2. **Data Cleaning**:\n",
    "   In this step, I addressed missing values and inconsistencies:\n",
    "   - I filled missing data with \"Unknown\" or removed rows/columns that contained too many missing values.\n",
    "   - This ensured that the analysis could proceed without errors or bias due to missing data.\n",
    "   - I also removed duplicates to maintain data integrity and normalized text columns (e.g., lowercasing and stripping whitespace) for consistency.\n",
    "\n",
    "3. **Substitute Analysis**:\n",
    "   I analyzed the availability of substitutes for each medicine:\n",
    "   - I counted how many substitutes each drug had by considering the columns for substitute names.\n",
    "   - I explored the top medicines with the most substitutes to understand which drugs have readily available alternatives.\n",
    "   - This is valuable in understanding the drug market and providing patients with more treatment options.\n",
    "\n",
    "4. **Side Effect Analysis**:\n",
    "   Side effects were another key focus:\n",
    "   - I combined the various columns for side effects (up to 41 different columns) into one to assess the frequency of each side effect.\n",
    "   - I identified the most common side effects across all medicines, such as nausea, vomiting, diarrhea, and abdominal pain, which could indicate general trends in medication safety.\n",
    "   - This analysis helps in pharmacovigilance by identifying patterns in adverse reactions.\n",
    "\n",
    "5. **Use Case Analysis**:\n",
    "   I explored the therapeutic uses of the medicines by:\n",
    "   - Combining the columns for different uses (up to 5 different uses per drug) and identifying the most common treatments provided by these medicines.\n",
    "   - I found that conditions such as bacterial infections, pain relief, and type 2 diabetes treatment were among the most frequent.\n",
    "   - This analysis provides insights into the most prevalent conditions treated by the pharmaceutical industry.\n",
    "\n",
    "6. **Classification Analysis**:\n",
    "   To better understand patterns in drug properties, I grouped medicines based on:\n",
    "   - **Chemical Class**: Medicines with similar chemical structures were grouped, and I analyzed how side effects varied across these groups.\n",
    "   - **Therapeutic Class**: I classified medicines according to their therapeutic uses (e.g., respiratory, anti-infectives).\n",
    "   - **Action Class**: Medicines were also grouped by their actions (e.g., H2 receptor blockers), and I examined the side effects associated with these classes.\n",
    "   - This classification allowed I to identify trends and similarities across medicines with similar intended purposes or mechanisms.\n",
    "\n",
    "7. **Visualization**:\n",
    "   To enhance the understanding of Ir findings, I created visualizations:\n",
    "   - I used tools like Matplotlib and Seaborn to visualize distributions, correlations, and patterns in side effects, substitutes, and usage.\n",
    "   - This provided clear, interpretable results for stakeholders in drug research or healthcare.\n",
    "\n",
    "8. **Advanced Analysis (Optional)**:\n",
    "   - The project suggests further exploration using clustering or machine learning techniques, such as building models to predict side effects based on the chemical or therapeutic class of a medicine.\n",
    "   - This could help in automating the process of identifying potential adverse reactions, thus aiding drug development and safety protocols.\n",
    "\n",
    "### Conclusion:\n",
    "The project successfully explored the relationships between medicines, their substitutes, side effects, and therapeutic uses. Key findings included identifying the most common side effects (such as nausea, diarrhea, and vomiting), recognizing medicines with the most substitutes, and analyzing the variation of these factors across different chemical, therapeutic, and action classes. The insights derived from this project are valuable for drug safety, healthcare planning, and research in the pharmaceutical industry. \n",
    "\n",
    "This analysis could be extended with more advanced techniques such as clustering, predictive modeling, and deeper exploration of correlations between drug classes and their effects, helping to refine drug recommendations or safety guidelines.\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "ab8de2e1-bfa5-407f-819d-8e9d27ff0385",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
